Given name(s)
Andrew
Family name
Dunn
Degrees
MD

When Should Antiplatelet Agents and Anticoagulants Be Restarted after Gastrointestinal Bleed?

Article Type
Changed
Fri, 09/14/2018 - 12:16
Display Headline
When Should Antiplatelet Agents and Anticoagulants Be Restarted after Gastrointestinal Bleed?

 

click for large version
Table 1: Risk stratification for thromboembolism
Source: Adapted from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.

Two Cases

A 76-year-old female with a history of hypertension, diabetes, atrial fibrillation, and diverticulosis is admitted with acute onset of dizziness and several episodes of bright red blood per rectum. Her labs show a new anemia at hemoglobin level 6.9 g/dL and an international normalized ratio (INR) of 2.7. She is transfused several units of packed red blood cells and fresh frozen plasma without further bleeding. She undergoes an esophagogastroduodenoscopy (EGD) and colonoscopy, which are notable only for extensive diverticulosis. In preparing the discharge medication reconciliation, you are uncertain what to do with the patient’s anticoagulation.

An 85-year-old male with coronary artery disease status post-percutaneous coronary intervention, with placement of a drug-eluting stent several years prior, is admitted with multiple weeks of epigastric discomfort and acute onset of hematemesis. His laboratory tests are notable for a new anemia at hemoglobin level 6.5 g/dL. Urgent EGD demonstrates a bleeding ulcer, which is cauterized. He is started on a proton-pump inhibitor (PPI). He inquires as to when he can restart his home medications, including aspirin.

Overview

Gastrointestinal (GI) bleeding is a serious complication of anticoagulant and antiplatelet therapy. Risks for GI bleeding include older age, history of peptic ulcer disease, NSAID or steroid use, and the use of antiplatelet or anticoagulation therapy. The estimated incidence of GI bleeding in the general population is 48 to 160 cases (upper GI) and 21 cases (lower GI) per 1,000 adults per year, with a case-mortality rate between 5% and 14%.1

Key Points

  • The decision to restart antiplatelet agents and/or anticoagulants should involve a patient-specific approach regarding potential risks and benefits.
  • For cases where the short-term benefit of anticoagulant or antiplatelet therapy outweighs the immediate risk, the appropriate agent can be restarted within four to five days of achieving hemostasis.
  • The hospitalist, specialist, longitudinal provider, and patient should all be engaged in decision-making for all patients.

Although there is consensus on ceasing anticoagulant and antiplatelet agents during an acute GI bleed, debate remains over the appropriate approach to restarting these agents.

Anticoagulant Resumption

A recent study published in Archives of Internal Medicine supports a quick resumption of anticoagulation following a GI bleed.2 Although previous studies on restarting anticoagulants were small and demonstrated mixed results, this retrospective cohort study examined more than 442 warfarin-associated GI bleeds. After adjusting for various clinical indicators (e.g. clinical seriousness of bleeding, requirement of transfusions), the investigators found that the decision not to resume warfarin within 90 days of an initial GI hemorrhage was associated with an increased risk of thrombosis and death. Of note, in those patients restarted on warfarin, the mean time to medication initiation was four days following the initial GI bleed. In those not restarted on warfarin, the earliest incidence of thrombosis was documented at eight days following cessation of anticoagulation.2

Though its clinical implications are limited by the retrospective design, this study is helpful in guiding management decisions. Randomized control trials and society recommendations on this topic are lacking, so the decision to resume anticoagulants rests on patient-specific estimates of the risk of recurrent bleeding and the benefits of resuming anticoagulants.

In identifying those patients most likely to benefit from restarting anticoagulation, the risk of thromboembolism should be determined using an established risk stratification framework, such as Antithrombotic Therapy and Prevention of Thrombosis, 9th edition (see Table 1).3 According to the guidelines, patients at highest risk of thromboembolism (in the absence of anticoagulation) are those with:

  • mitral valve prostheses;
  • atrial fibrillation with a CHADS2 score of five to six or cerebrovascular accidents (CVA) within the last three months; and/or
  • venous thromboembolism (VTE) within the last three months or history of severe thrombophilia.
 

 

Patients at the lowest risk of thromboembolism are those with:

  • mechanical aortic prostheses with no other stroke risk factors;
  • atrial fibrillation with a CHADS2 score of zero to two; and/or
  • a single VTE that occurred >12 months prior.

There are several approaches to identifying patients at greatest risk for bleeding. Location-specific modeling for upper GI bleeds (e.g. Rockall score) and lower GI bleeds (e.g. BLEED score) focus on the clinical presentation and/or endoscopic findings. General hemorrhage risk scores (e.g. HAS-BLED, ATRIA) focus on medical comorbidities. While easy to use, the predictive value of such scores as part of anticoagulation resumption after a GI hemorrhage remains uncertain.

Based on the above methods of risk stratification, patients at higher risk of thromboembolism and lower risk of bleeding will likely benefit from waiting only a short time interval before restarting anticoagulation. Based on the trial conducted by Witt and colleagues, anticoagulation typically can be reinitiated within four days of obtaining hemostatic and hemodynamic stability.2 Conversely, those at highest risk of bleeding and lower risk of thromboembolism will benefit from a delayed resumption of anticoagulation. Involvement of a specialist, such as a gastroenterologist, could help further clarify the risk of rebleeding.

The ideal approach for patients with a high risk of both bleeding and thromboembolism remains uncertain. Such cases highlight the need for an informed discussion with the patient and any involved caregivers, as well as involvement of inpatient subspecialists and outpatient longitudinal providers.

There remains a lack of evidence on the best method to restart anticoagulation. Based on small and retrospective trials, we recommend restarting warfarin at the patient’s previous home dose. The duration of inpatient monitoring following warfarin initiation should be individualized, but warfarin is not expected to impair coagulation for four to six days after initiation.

Little data is available with respect to the role of novel oral anticoagulants after a GI bleed. Given the lack of reversing agents for these drugs, we recommend exercising caution in populations with a high risk of rebleeding. Theoretically, given that these agents reach peak effect faster than warfarin, waiting an additional four days after the time frame recommended for starting warfarin is a prudent resumption strategy for novel oral anticoagulants.

click for large version
Table 1: Risk stratification for thromboembolism
Source: Adapted from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.

Resumption of Antiplatelet Agents

The decision to resume antiplatelet therapy should also be highly individualized. In addition to weighing the risk of bleeding (as described in the previous section), the physician must also estimate the benefits of antiplatelet therapy in decreasing the risk of cardiovascular events.

In low-risk patients on antiplatelet therapy (i.e., for primary cardiovascular prevention) reinitiation after a bleeding episode can be reasonably delayed, because the risk of rebleeding likely outweighs the potential benefit of restarting therapy.

For patients who are at intermediate risk (i.e., those on antiplatelet agents for secondary prevention of cardiovascular disease), emerging evidence argues for early reinstitution after a GI bleed. In a trial published in Annals of Internal Medicine, Sung and colleagues randomized 156 patients to aspirin or placebo therapy immediately following endoscopically obtained hemostasis for peptic ulcer bleeding.4 All patients received PPIs. There was no significant difference in bleeding rates between the two groups, but delayed resumption of aspirin was associated with a significant increase in all-cause mortality.

Additional Reading

  • Almadi MA, Barkun A, Brophy J. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: An 86-year-old woman with peptic ulcer disease. JAMA. 2011;306(21):2367-2374.
  • Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH. Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy. J Clin Gastroenterol. 2009;43(1):5-12.

 

 

Two recent meta-analyses provide further insight into the risks of withholding aspirin therapy. The first, which included 50,279 patients on aspirin for secondary prevention, found that aspirin non-adherence or withdrawal after a GI bleed was associated with a three-fold higher risk of major adverse cardiac events.5 Cardiac event rates were highest in the subgroup of patients with a history of prior percutaneous coronary stenting.

A second meta-analysis evaluated patients who had aspirin held perioperatively. In a population of patients on aspirin for secondary prevention, the mean time after withholding aspirin was 8.5 days to coronary events, 14.3 days to cerebrovascular events, and 25.8 days to peripheral arterial events.6 Events occurred as early as five days after withdrawal of aspirin.

Patients with recent intracoronary stenting are at highest risk of thrombosis. In patients with a bare metal stent placed within six weeks, or a drug-eluting stent placed within six months, every effort should be made to minimize interruptions of dual antiplatelet therapy.

Based on the data presented above, for patients at intermediate and/or high risk of adverse cardiac events, we recommend reinstitution of aspirin as soon as possible following a GI hemorrhage, preferably within five days. PPI co-therapy is a mainstay for secondary prevention of upper GI bleeding in patients on antiplatelet therapy. Current research and guidelines have not addressed specifically the role of withholding and reinitiating aspirin in lower GI bleeding, non-peptic ulcer, or upper-GI bleeding, however, a similar strategy is likely appropriate. As with the decision for restarting anticoagulants, discussion with relevant specialists is essential to best define the risk of re-bleeding.

Based on the trial conducted by Witt and colleagues, anticoagulation typically can be reinitiated within four days of obtaining hemostatic and hemodynamic stability. Conversely, those at highest risk of bleeding and lower risk of thromboembolism will benefit from a delayed resumption of anticoagulation.

Back to the Cases

Given her CHADS2 score of three, the patient with a diverticular bleed has a 9.6% annual risk of stroke if she does not resume anticoagulation. Using the HAS-BLED and ATRIA scores, this patient has 2.6% to 5.8% annual risk of hemorrhage. We recommend resuming warfarin anticoagulation therapy within four days of achieving hemostasis.

For the patient with coronary artery disease with remote drug-eluting stent placement and upper GI bleed, evidence supports early resumption of appropriate antiplatelet therapy following endoscopic therapy and hemostasis. We recommend resuming aspirin during the current hospitalization and concomitant treatment with a PPI indefinitely.

Bottom Line

Following a GI bleed, the risks and benefits of restarting anticoagulant and antiplatelet agents need to be carefully considered. In patients on oral anticoagulants at high risk for thromboembolism and low risk for rebleeding, consider restarting anticoagulation within four to five days. Patients on antiplatelet agents for secondary prevention should have the medication restarted during hospitalization after endoscopically obtained hemostasis of a peptic ulcer.

In all cases, hospitalists should engage the patient, gastroenterologist, and outpatient provider to best determine when resumption of anticoagulant and/or antiplatelet agents should occur.


Dr. Allen-Dicker is a hospitalist and clinical instructor at Mount Sinai Medical Center in New York City. Dr. Briones is director of perioperative services in the division of hospital medicine and an assistant professor; Dr. Berman is a hospitalist and a clinical instructor, and Dr. Dunn is a professor of medicine and chief of the division of hospital medicine, all at Mount Sinai Medical Center.

References

  1. Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101-113.
  2. Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19):1484-1491.
  3. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.
  4. Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: A randomized trial. Ann Intern Med. 2010;152(1):1-9.
  5. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667-2674.
  6. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med. 2005;257(5):399-414.
 

 

Issue
The Hospitalist - 2013(12)
Publications
Sections

 

click for large version
Table 1: Risk stratification for thromboembolism
Source: Adapted from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.

Two Cases

A 76-year-old female with a history of hypertension, diabetes, atrial fibrillation, and diverticulosis is admitted with acute onset of dizziness and several episodes of bright red blood per rectum. Her labs show a new anemia at hemoglobin level 6.9 g/dL and an international normalized ratio (INR) of 2.7. She is transfused several units of packed red blood cells and fresh frozen plasma without further bleeding. She undergoes an esophagogastroduodenoscopy (EGD) and colonoscopy, which are notable only for extensive diverticulosis. In preparing the discharge medication reconciliation, you are uncertain what to do with the patient’s anticoagulation.

An 85-year-old male with coronary artery disease status post-percutaneous coronary intervention, with placement of a drug-eluting stent several years prior, is admitted with multiple weeks of epigastric discomfort and acute onset of hematemesis. His laboratory tests are notable for a new anemia at hemoglobin level 6.5 g/dL. Urgent EGD demonstrates a bleeding ulcer, which is cauterized. He is started on a proton-pump inhibitor (PPI). He inquires as to when he can restart his home medications, including aspirin.

Overview

Gastrointestinal (GI) bleeding is a serious complication of anticoagulant and antiplatelet therapy. Risks for GI bleeding include older age, history of peptic ulcer disease, NSAID or steroid use, and the use of antiplatelet or anticoagulation therapy. The estimated incidence of GI bleeding in the general population is 48 to 160 cases (upper GI) and 21 cases (lower GI) per 1,000 adults per year, with a case-mortality rate between 5% and 14%.1

Key Points

  • The decision to restart antiplatelet agents and/or anticoagulants should involve a patient-specific approach regarding potential risks and benefits.
  • For cases where the short-term benefit of anticoagulant or antiplatelet therapy outweighs the immediate risk, the appropriate agent can be restarted within four to five days of achieving hemostasis.
  • The hospitalist, specialist, longitudinal provider, and patient should all be engaged in decision-making for all patients.

Although there is consensus on ceasing anticoagulant and antiplatelet agents during an acute GI bleed, debate remains over the appropriate approach to restarting these agents.

Anticoagulant Resumption

A recent study published in Archives of Internal Medicine supports a quick resumption of anticoagulation following a GI bleed.2 Although previous studies on restarting anticoagulants were small and demonstrated mixed results, this retrospective cohort study examined more than 442 warfarin-associated GI bleeds. After adjusting for various clinical indicators (e.g. clinical seriousness of bleeding, requirement of transfusions), the investigators found that the decision not to resume warfarin within 90 days of an initial GI hemorrhage was associated with an increased risk of thrombosis and death. Of note, in those patients restarted on warfarin, the mean time to medication initiation was four days following the initial GI bleed. In those not restarted on warfarin, the earliest incidence of thrombosis was documented at eight days following cessation of anticoagulation.2

Though its clinical implications are limited by the retrospective design, this study is helpful in guiding management decisions. Randomized control trials and society recommendations on this topic are lacking, so the decision to resume anticoagulants rests on patient-specific estimates of the risk of recurrent bleeding and the benefits of resuming anticoagulants.

In identifying those patients most likely to benefit from restarting anticoagulation, the risk of thromboembolism should be determined using an established risk stratification framework, such as Antithrombotic Therapy and Prevention of Thrombosis, 9th edition (see Table 1).3 According to the guidelines, patients at highest risk of thromboembolism (in the absence of anticoagulation) are those with:

  • mitral valve prostheses;
  • atrial fibrillation with a CHADS2 score of five to six or cerebrovascular accidents (CVA) within the last three months; and/or
  • venous thromboembolism (VTE) within the last three months or history of severe thrombophilia.
 

 

Patients at the lowest risk of thromboembolism are those with:

  • mechanical aortic prostheses with no other stroke risk factors;
  • atrial fibrillation with a CHADS2 score of zero to two; and/or
  • a single VTE that occurred >12 months prior.

There are several approaches to identifying patients at greatest risk for bleeding. Location-specific modeling for upper GI bleeds (e.g. Rockall score) and lower GI bleeds (e.g. BLEED score) focus on the clinical presentation and/or endoscopic findings. General hemorrhage risk scores (e.g. HAS-BLED, ATRIA) focus on medical comorbidities. While easy to use, the predictive value of such scores as part of anticoagulation resumption after a GI hemorrhage remains uncertain.

Based on the above methods of risk stratification, patients at higher risk of thromboembolism and lower risk of bleeding will likely benefit from waiting only a short time interval before restarting anticoagulation. Based on the trial conducted by Witt and colleagues, anticoagulation typically can be reinitiated within four days of obtaining hemostatic and hemodynamic stability.2 Conversely, those at highest risk of bleeding and lower risk of thromboembolism will benefit from a delayed resumption of anticoagulation. Involvement of a specialist, such as a gastroenterologist, could help further clarify the risk of rebleeding.

The ideal approach for patients with a high risk of both bleeding and thromboembolism remains uncertain. Such cases highlight the need for an informed discussion with the patient and any involved caregivers, as well as involvement of inpatient subspecialists and outpatient longitudinal providers.

There remains a lack of evidence on the best method to restart anticoagulation. Based on small and retrospective trials, we recommend restarting warfarin at the patient’s previous home dose. The duration of inpatient monitoring following warfarin initiation should be individualized, but warfarin is not expected to impair coagulation for four to six days after initiation.

Little data is available with respect to the role of novel oral anticoagulants after a GI bleed. Given the lack of reversing agents for these drugs, we recommend exercising caution in populations with a high risk of rebleeding. Theoretically, given that these agents reach peak effect faster than warfarin, waiting an additional four days after the time frame recommended for starting warfarin is a prudent resumption strategy for novel oral anticoagulants.

click for large version
Table 1: Risk stratification for thromboembolism
Source: Adapted from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.

Resumption of Antiplatelet Agents

The decision to resume antiplatelet therapy should also be highly individualized. In addition to weighing the risk of bleeding (as described in the previous section), the physician must also estimate the benefits of antiplatelet therapy in decreasing the risk of cardiovascular events.

In low-risk patients on antiplatelet therapy (i.e., for primary cardiovascular prevention) reinitiation after a bleeding episode can be reasonably delayed, because the risk of rebleeding likely outweighs the potential benefit of restarting therapy.

For patients who are at intermediate risk (i.e., those on antiplatelet agents for secondary prevention of cardiovascular disease), emerging evidence argues for early reinstitution after a GI bleed. In a trial published in Annals of Internal Medicine, Sung and colleagues randomized 156 patients to aspirin or placebo therapy immediately following endoscopically obtained hemostasis for peptic ulcer bleeding.4 All patients received PPIs. There was no significant difference in bleeding rates between the two groups, but delayed resumption of aspirin was associated with a significant increase in all-cause mortality.

Additional Reading

  • Almadi MA, Barkun A, Brophy J. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: An 86-year-old woman with peptic ulcer disease. JAMA. 2011;306(21):2367-2374.
  • Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH. Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy. J Clin Gastroenterol. 2009;43(1):5-12.

 

 

Two recent meta-analyses provide further insight into the risks of withholding aspirin therapy. The first, which included 50,279 patients on aspirin for secondary prevention, found that aspirin non-adherence or withdrawal after a GI bleed was associated with a three-fold higher risk of major adverse cardiac events.5 Cardiac event rates were highest in the subgroup of patients with a history of prior percutaneous coronary stenting.

A second meta-analysis evaluated patients who had aspirin held perioperatively. In a population of patients on aspirin for secondary prevention, the mean time after withholding aspirin was 8.5 days to coronary events, 14.3 days to cerebrovascular events, and 25.8 days to peripheral arterial events.6 Events occurred as early as five days after withdrawal of aspirin.

Patients with recent intracoronary stenting are at highest risk of thrombosis. In patients with a bare metal stent placed within six weeks, or a drug-eluting stent placed within six months, every effort should be made to minimize interruptions of dual antiplatelet therapy.

Based on the data presented above, for patients at intermediate and/or high risk of adverse cardiac events, we recommend reinstitution of aspirin as soon as possible following a GI hemorrhage, preferably within five days. PPI co-therapy is a mainstay for secondary prevention of upper GI bleeding in patients on antiplatelet therapy. Current research and guidelines have not addressed specifically the role of withholding and reinitiating aspirin in lower GI bleeding, non-peptic ulcer, or upper-GI bleeding, however, a similar strategy is likely appropriate. As with the decision for restarting anticoagulants, discussion with relevant specialists is essential to best define the risk of re-bleeding.

Based on the trial conducted by Witt and colleagues, anticoagulation typically can be reinitiated within four days of obtaining hemostatic and hemodynamic stability. Conversely, those at highest risk of bleeding and lower risk of thromboembolism will benefit from a delayed resumption of anticoagulation.

Back to the Cases

Given her CHADS2 score of three, the patient with a diverticular bleed has a 9.6% annual risk of stroke if she does not resume anticoagulation. Using the HAS-BLED and ATRIA scores, this patient has 2.6% to 5.8% annual risk of hemorrhage. We recommend resuming warfarin anticoagulation therapy within four days of achieving hemostasis.

For the patient with coronary artery disease with remote drug-eluting stent placement and upper GI bleed, evidence supports early resumption of appropriate antiplatelet therapy following endoscopic therapy and hemostasis. We recommend resuming aspirin during the current hospitalization and concomitant treatment with a PPI indefinitely.

Bottom Line

Following a GI bleed, the risks and benefits of restarting anticoagulant and antiplatelet agents need to be carefully considered. In patients on oral anticoagulants at high risk for thromboembolism and low risk for rebleeding, consider restarting anticoagulation within four to five days. Patients on antiplatelet agents for secondary prevention should have the medication restarted during hospitalization after endoscopically obtained hemostasis of a peptic ulcer.

In all cases, hospitalists should engage the patient, gastroenterologist, and outpatient provider to best determine when resumption of anticoagulant and/or antiplatelet agents should occur.


Dr. Allen-Dicker is a hospitalist and clinical instructor at Mount Sinai Medical Center in New York City. Dr. Briones is director of perioperative services in the division of hospital medicine and an assistant professor; Dr. Berman is a hospitalist and a clinical instructor, and Dr. Dunn is a professor of medicine and chief of the division of hospital medicine, all at Mount Sinai Medical Center.

References

  1. Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101-113.
  2. Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19):1484-1491.
  3. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.
  4. Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: A randomized trial. Ann Intern Med. 2010;152(1):1-9.
  5. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667-2674.
  6. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med. 2005;257(5):399-414.
 

 

 

click for large version
Table 1: Risk stratification for thromboembolism
Source: Adapted from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.

Two Cases

A 76-year-old female with a history of hypertension, diabetes, atrial fibrillation, and diverticulosis is admitted with acute onset of dizziness and several episodes of bright red blood per rectum. Her labs show a new anemia at hemoglobin level 6.9 g/dL and an international normalized ratio (INR) of 2.7. She is transfused several units of packed red blood cells and fresh frozen plasma without further bleeding. She undergoes an esophagogastroduodenoscopy (EGD) and colonoscopy, which are notable only for extensive diverticulosis. In preparing the discharge medication reconciliation, you are uncertain what to do with the patient’s anticoagulation.

An 85-year-old male with coronary artery disease status post-percutaneous coronary intervention, with placement of a drug-eluting stent several years prior, is admitted with multiple weeks of epigastric discomfort and acute onset of hematemesis. His laboratory tests are notable for a new anemia at hemoglobin level 6.5 g/dL. Urgent EGD demonstrates a bleeding ulcer, which is cauterized. He is started on a proton-pump inhibitor (PPI). He inquires as to when he can restart his home medications, including aspirin.

Overview

Gastrointestinal (GI) bleeding is a serious complication of anticoagulant and antiplatelet therapy. Risks for GI bleeding include older age, history of peptic ulcer disease, NSAID or steroid use, and the use of antiplatelet or anticoagulation therapy. The estimated incidence of GI bleeding in the general population is 48 to 160 cases (upper GI) and 21 cases (lower GI) per 1,000 adults per year, with a case-mortality rate between 5% and 14%.1

Key Points

  • The decision to restart antiplatelet agents and/or anticoagulants should involve a patient-specific approach regarding potential risks and benefits.
  • For cases where the short-term benefit of anticoagulant or antiplatelet therapy outweighs the immediate risk, the appropriate agent can be restarted within four to five days of achieving hemostasis.
  • The hospitalist, specialist, longitudinal provider, and patient should all be engaged in decision-making for all patients.

Although there is consensus on ceasing anticoagulant and antiplatelet agents during an acute GI bleed, debate remains over the appropriate approach to restarting these agents.

Anticoagulant Resumption

A recent study published in Archives of Internal Medicine supports a quick resumption of anticoagulation following a GI bleed.2 Although previous studies on restarting anticoagulants were small and demonstrated mixed results, this retrospective cohort study examined more than 442 warfarin-associated GI bleeds. After adjusting for various clinical indicators (e.g. clinical seriousness of bleeding, requirement of transfusions), the investigators found that the decision not to resume warfarin within 90 days of an initial GI hemorrhage was associated with an increased risk of thrombosis and death. Of note, in those patients restarted on warfarin, the mean time to medication initiation was four days following the initial GI bleed. In those not restarted on warfarin, the earliest incidence of thrombosis was documented at eight days following cessation of anticoagulation.2

Though its clinical implications are limited by the retrospective design, this study is helpful in guiding management decisions. Randomized control trials and society recommendations on this topic are lacking, so the decision to resume anticoagulants rests on patient-specific estimates of the risk of recurrent bleeding and the benefits of resuming anticoagulants.

In identifying those patients most likely to benefit from restarting anticoagulation, the risk of thromboembolism should be determined using an established risk stratification framework, such as Antithrombotic Therapy and Prevention of Thrombosis, 9th edition (see Table 1).3 According to the guidelines, patients at highest risk of thromboembolism (in the absence of anticoagulation) are those with:

  • mitral valve prostheses;
  • atrial fibrillation with a CHADS2 score of five to six or cerebrovascular accidents (CVA) within the last three months; and/or
  • venous thromboembolism (VTE) within the last three months or history of severe thrombophilia.
 

 

Patients at the lowest risk of thromboembolism are those with:

  • mechanical aortic prostheses with no other stroke risk factors;
  • atrial fibrillation with a CHADS2 score of zero to two; and/or
  • a single VTE that occurred >12 months prior.

There are several approaches to identifying patients at greatest risk for bleeding. Location-specific modeling for upper GI bleeds (e.g. Rockall score) and lower GI bleeds (e.g. BLEED score) focus on the clinical presentation and/or endoscopic findings. General hemorrhage risk scores (e.g. HAS-BLED, ATRIA) focus on medical comorbidities. While easy to use, the predictive value of such scores as part of anticoagulation resumption after a GI hemorrhage remains uncertain.

Based on the above methods of risk stratification, patients at higher risk of thromboembolism and lower risk of bleeding will likely benefit from waiting only a short time interval before restarting anticoagulation. Based on the trial conducted by Witt and colleagues, anticoagulation typically can be reinitiated within four days of obtaining hemostatic and hemodynamic stability.2 Conversely, those at highest risk of bleeding and lower risk of thromboembolism will benefit from a delayed resumption of anticoagulation. Involvement of a specialist, such as a gastroenterologist, could help further clarify the risk of rebleeding.

The ideal approach for patients with a high risk of both bleeding and thromboembolism remains uncertain. Such cases highlight the need for an informed discussion with the patient and any involved caregivers, as well as involvement of inpatient subspecialists and outpatient longitudinal providers.

There remains a lack of evidence on the best method to restart anticoagulation. Based on small and retrospective trials, we recommend restarting warfarin at the patient’s previous home dose. The duration of inpatient monitoring following warfarin initiation should be individualized, but warfarin is not expected to impair coagulation for four to six days after initiation.

Little data is available with respect to the role of novel oral anticoagulants after a GI bleed. Given the lack of reversing agents for these drugs, we recommend exercising caution in populations with a high risk of rebleeding. Theoretically, given that these agents reach peak effect faster than warfarin, waiting an additional four days after the time frame recommended for starting warfarin is a prudent resumption strategy for novel oral anticoagulants.

click for large version
Table 1: Risk stratification for thromboembolism
Source: Adapted from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.

Resumption of Antiplatelet Agents

The decision to resume antiplatelet therapy should also be highly individualized. In addition to weighing the risk of bleeding (as described in the previous section), the physician must also estimate the benefits of antiplatelet therapy in decreasing the risk of cardiovascular events.

In low-risk patients on antiplatelet therapy (i.e., for primary cardiovascular prevention) reinitiation after a bleeding episode can be reasonably delayed, because the risk of rebleeding likely outweighs the potential benefit of restarting therapy.

For patients who are at intermediate risk (i.e., those on antiplatelet agents for secondary prevention of cardiovascular disease), emerging evidence argues for early reinstitution after a GI bleed. In a trial published in Annals of Internal Medicine, Sung and colleagues randomized 156 patients to aspirin or placebo therapy immediately following endoscopically obtained hemostasis for peptic ulcer bleeding.4 All patients received PPIs. There was no significant difference in bleeding rates between the two groups, but delayed resumption of aspirin was associated with a significant increase in all-cause mortality.

Additional Reading

  • Almadi MA, Barkun A, Brophy J. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: An 86-year-old woman with peptic ulcer disease. JAMA. 2011;306(21):2367-2374.
  • Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH. Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy. J Clin Gastroenterol. 2009;43(1):5-12.

 

 

Two recent meta-analyses provide further insight into the risks of withholding aspirin therapy. The first, which included 50,279 patients on aspirin for secondary prevention, found that aspirin non-adherence or withdrawal after a GI bleed was associated with a three-fold higher risk of major adverse cardiac events.5 Cardiac event rates were highest in the subgroup of patients with a history of prior percutaneous coronary stenting.

A second meta-analysis evaluated patients who had aspirin held perioperatively. In a population of patients on aspirin for secondary prevention, the mean time after withholding aspirin was 8.5 days to coronary events, 14.3 days to cerebrovascular events, and 25.8 days to peripheral arterial events.6 Events occurred as early as five days after withdrawal of aspirin.

Patients with recent intracoronary stenting are at highest risk of thrombosis. In patients with a bare metal stent placed within six weeks, or a drug-eluting stent placed within six months, every effort should be made to minimize interruptions of dual antiplatelet therapy.

Based on the data presented above, for patients at intermediate and/or high risk of adverse cardiac events, we recommend reinstitution of aspirin as soon as possible following a GI hemorrhage, preferably within five days. PPI co-therapy is a mainstay for secondary prevention of upper GI bleeding in patients on antiplatelet therapy. Current research and guidelines have not addressed specifically the role of withholding and reinitiating aspirin in lower GI bleeding, non-peptic ulcer, or upper-GI bleeding, however, a similar strategy is likely appropriate. As with the decision for restarting anticoagulants, discussion with relevant specialists is essential to best define the risk of re-bleeding.

Based on the trial conducted by Witt and colleagues, anticoagulation typically can be reinitiated within four days of obtaining hemostatic and hemodynamic stability. Conversely, those at highest risk of bleeding and lower risk of thromboembolism will benefit from a delayed resumption of anticoagulation.

Back to the Cases

Given her CHADS2 score of three, the patient with a diverticular bleed has a 9.6% annual risk of stroke if she does not resume anticoagulation. Using the HAS-BLED and ATRIA scores, this patient has 2.6% to 5.8% annual risk of hemorrhage. We recommend resuming warfarin anticoagulation therapy within four days of achieving hemostasis.

For the patient with coronary artery disease with remote drug-eluting stent placement and upper GI bleed, evidence supports early resumption of appropriate antiplatelet therapy following endoscopic therapy and hemostasis. We recommend resuming aspirin during the current hospitalization and concomitant treatment with a PPI indefinitely.

Bottom Line

Following a GI bleed, the risks and benefits of restarting anticoagulant and antiplatelet agents need to be carefully considered. In patients on oral anticoagulants at high risk for thromboembolism and low risk for rebleeding, consider restarting anticoagulation within four to five days. Patients on antiplatelet agents for secondary prevention should have the medication restarted during hospitalization after endoscopically obtained hemostasis of a peptic ulcer.

In all cases, hospitalists should engage the patient, gastroenterologist, and outpatient provider to best determine when resumption of anticoagulant and/or antiplatelet agents should occur.


Dr. Allen-Dicker is a hospitalist and clinical instructor at Mount Sinai Medical Center in New York City. Dr. Briones is director of perioperative services in the division of hospital medicine and an assistant professor; Dr. Berman is a hospitalist and a clinical instructor, and Dr. Dunn is a professor of medicine and chief of the division of hospital medicine, all at Mount Sinai Medical Center.

References

  1. Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101-113.
  2. Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19):1484-1491.
  3. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-350S.
  4. Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: A randomized trial. Ann Intern Med. 2010;152(1):1-9.
  5. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667-2674.
  6. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med. 2005;257(5):399-414.
 

 

Issue
The Hospitalist - 2013(12)
Issue
The Hospitalist - 2013(12)
Publications
Publications
Article Type
Display Headline
When Should Antiplatelet Agents and Anticoagulants Be Restarted after Gastrointestinal Bleed?
Display Headline
When Should Antiplatelet Agents and Anticoagulants Be Restarted after Gastrointestinal Bleed?
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Hospital LOS in the Homebound Population

Article Type
Changed
Mon, 05/22/2017 - 19:45
Display Headline
Nonmedical factors associated with prolonged hospital length of stay in an urban homebound population

In recent years, much attention has been paid to concerns regarding length of stay (LOS) and safety of hospital discharges.13 Yet studies conducted in a variety of populations suggest that long stays do not wholly reflect acute medical necessity, but may also be driven by nonmedical factors.46 In a study of frail elderly patients, nonmedical factors accounted for over half of patients' hospital stay days.5 Nonmedical factors may include the availability of community and outpatient resources, inadequate patient social support, disagreement with family and/or patient decision‐making, and post‐hospital placement and care needs.7

Homebound patients are at particular risk for long stays because they are typically frail, elderly, and medically complex.8 The United States homebound population numbers at least 2 million and is expected to increase to at least 3 million by the year 2020.9 This group is medically underserved, often only receiving care for medical emergencies, and represents a costly group of health care beneficiaries.10 Although homebound primary care (HBPC) programs are structured to provide coordinated medical and supportive care in the home, the clinical complexity of patients often requires hospitalization during times of acute illness.11

Navigating the discharge process for homebound patients can prove time‐consuming for inpatient physicians whose clinical obligations encompass ensuring safe care transitions between hospital and home.12 The lack of literature on the discharge needs of the homebound population provides little guidance for physicians and health systems seeking to safely transition homebound patients from the hospital to the home in a timely and efficient manner. We performed a pilot study of an urban homebound population cared for by a single academic homebound program to identify and describe nonmedical factors associated with prolonged hospitalization.

METHODS

This retrospective descriptive study included homebound patients cared for by The Mount Sinai Visiting Doctors Program (MSVD), a primary care program affiliated with The Mount Sinai Hospital. MSVD is the largest academic homebound primary care program in the United States. The structure and patient population of MSVD patients have been described previously.13 Briefly, the program employs 8 physicians, 2 nurse practitioners, and support personnel including 2 registered nurses, 4 social workers, and 4 clerical staff members to serve over 1000 homebound patients annually. To be enrolled in the program, patients must meet the Medicare definition of homebound (ie, they must be able to leave home only with great difficulty and for infrequent or short absences). Patients are referred from a variety of sources including emergency rooms, inpatient units, and local nursing and social service agencies. Physicians visit patients on average once every 2 months, but can make more frequent home visits when a clinical need arises. Thirty‐six percent of patients in the program are hospitalized at least once per year while they are under the MSVD's care.14 Patients in the MSVD are referred by their primary care physician to outpatient social work as needed for finite interventions, though not for ongoing case management; approximately one‐third of all MSVD patients have been seen by an MSVD social worker over a 1‐year period.14

All patients enrolled in MSVD discharged from The Mount Sinai Hospital in New York from January 1, 2007, to December 31, 2007, were evaluated for inclusion in this study. The MSVD clinical database was cross‐referenced with The Mount Sinai Hospital data system to maximize reliability of recorded admission and discharge dates. Discrepancies in dates were investigated and corrected by the authors. As the study focused on admissions rather than individual patients, repeat hospitalizations and factors contributing to long stays were included and considered separately. In the event of repeat hospitalizations, factors contributing to LOS were also assessed separately.

Using the University HealthSystems Consortium (UHC) Database, the selected discharges were analyzed for LOS data. The UHC Database contains data from The Mount Sinai Hospital and 106 other academic medical centers and 233 other affiliated hospitals, representing approximately 90% of the United States' nonprofit academic medical centers. UHC members submit clinical, financial, and administrative information for the purpose of facilitating comparative data analysis among institutions.15 The model assigns an expected LOS for each patient based on a 4‐step risk adjustment methodology that adjusts for variations in patient characteristics. The regression models consider a range of independent variables including patient age, sex, race, socioeconomic status, admission source, and comorbid conditions. The expected LOS value is used to produce an LOS ratio, which is the ratio of a patient's observed LOS to expected LOS. We compared LOS ratios for all patient discharges during the study period and determined the mean LOS ratio for the group. Long‐stay patients were defined using the UHC definition of an LOS ratio greater than 2 standard deviations above the mean. These patients were selected for analysis to examine factors contributing to their long stays.

The primary author conducted a chart review for the long‐stay patients. The date of medical readiness for discharge was defined as the date when no acute hospital care needs or pending procedures (eg, intravenous medication, transfusion, invasive and noninvasive testing, surgery) were documented by the attending physician, house officer, nurse practitioner, or physician assistant in the chart. Patients with a discharge immediately following determination of medical readiness were characterized as having a medical stay (eg, patient admitted for pneumonia and discharged home after 3 days once fever, leukocytosis, and symptoms improved with a prescription for remaining antibiotic course). Patients who were classified as medically ready for discharge yet remained additional days in the hospital were categorized as having a nonmedical component to their hospitalization and comprised the nonmedical stay group (eg, patient admitted for pneumonia with improved vital signs and symptoms after 3 days, but discharged home after 10 days awaiting approval of increased home health aide hours). The primary author reviewed cases (<5%) with coauthors when categorization of patient data was unclear from physician documentation in the patient's chart. Similar methodology and terminology have been used in previous studies examining the contribution of nonmedical factors to LOS.5, 7

While literature in other fields, such as social work, often characterize similar factors as social or social care factors, we use the term nonmedical to draw the distinction between factors that acutely reflect a patient's state of health and necessitate days spent in the hospital (eg, surgery, infection), in contrast to factors that are not direct contributors to the patient's current medical status (eg, post‐hospital placement). Factors contributing to nonmedical days were determined based on previous studies and categorized as follows: nursing facility bed availability, nursing facility rejection of the patient, complications with insurance coverage, lack of patient/family agreement with discharge plan, home care service delays, and other. The category other was included to identify and explore any unexpected or unique reasons for prolongation of hospitalization in this population. When multiple nonmedical factors were identified for a given hospitalization, all contributing factors were recorded.

Demographic, clinical, and discharge characteristics were extracted from the MSVD clinical database to qualitatively describe and compare the long‐stay hospitalizations to the remainder of the sample.

RESULTS

There were a total of 479 discharges of 267 unique MSVD patients from The Mount Sinai Hospital occurring from January 1, 2007, to December 31, 2007. During this 12‐month period, the average observed LOS for all admissions was 7.84 days, with a mean UHC LOS ratio of 1.23 (SD = 3.43). Seventeen admissions were identified as long‐stays, representing 3.5% of discharges. The 17 admissions represent 17 unique patients.

As shown in Table 1, the long‐stay group (n = 17) was slightly younger, more likely to be male, and had less dementia than the nonlong‐stay group (n = 462). There was a marked difference in the location of patient discharge; long‐stay patients were more than twice as likely to be discharged to a facility and less likely to be discharged home. There were no in‐hospital deaths in the long‐stay patient group during the time period studied.

Demographic, Clinical, and Discharge Characteristics for 2007 Hospitalizations According to Length of Stay
Characteristics*NonLong‐Stay Patients (n = 462)Long‐Stay Patients (n = 17)
  • NOTE: Characteristics describe all hospitalizations and include multiple discharges per patient.

  • Abbreviation: SD, standard deviation.

Mean age, years (SD)80 (15.6)74 (18.2)
Female sex69%47%
Race  
Caucasian27.1%29%
Black31.4%23.5%
Hispanic37.7%41.2%
Other2.4%5.9%
Has Medicaid68.1%70.6%
Dementia diagnosis42.9%29.4%
Depression diagnosis37.3%47.1%
Lives alone39.8%43.8%
Discharge  
Nursing/rehabilitation14.9%35.3%
Home78.3%64.7%
Death5.9%0%
Hospice0.9%0%

Of the 17 long‐stay patients, 8 (47%) remained in the hospital past the date they were determined to be medically ready for discharge and were defined as having a nonmedical component for the extension of their hospitalizations. The number of nonmedical days ranged from 6 to 34 days (mean, 17 days). Out of 428 total long‐stay patient days, 136 were nonmedical. This represented 31.8% of all long‐stay patient days, and 53% of the nonmedical group's total hospital days. The mean LOS ratio for the nonmedical cases was 6.04 (Table 2).

Medical Stay and Nonmedical Stay Length of Stay Ratios
 Medical Stay (n = 9)Nonmedical Stay (n = 8)
  • Abbreviation: LOS, length of stay.

LOS (days)19.217
LOS ratio5.076.04

Nine patients were defined as medical stay cases (ie, no nonmedical component contributing to the long hospitalization). The mean observed LOS was 19.2 days, and the mean LOS ratio for this group was 5.07 (Table 2). There were no significant differences between primary diagnosis‐related groups (DRGs) seen in the medical and nonmedical stay groups.

The most common reason for a nonmedical stay was nursing facility placement delays (Table 3), specifically related to lack of bed availability and facility rejection of the patient leading to prolonged time waiting for long‐term placement (n = 6). Other nonmedical factors contributing to LOS were lack of patient and/or family agreement with discharge plans (eg, disagreement among family members regarding caregiving responsibilities, goals of care, or patient refusal to be discharged on a particular day) (n = 4); complications with insurance coverage for facility placement or for home care (n = 3); and home care service delays, such as patient need for increased home care hours after discharge (n = 2). Of note, 5 of the 8 nonmedical stay cases had multiple factors contributing to patients' long stays. All delays were assigned to one of the a priori defined categories. There were no other or unexpected reasons identified.

Characteristics of Nonmedical Long‐Stay Patients
PatientDemographicsExpected LOS (days)Observed LOS (days)LOS RatioNo. of Nonmedical DaysNonmedical Stay Factors
  • Abbreviation: LOS, length of stay.

Patient A63‐year‐old white man4.564810.5334Nursing facility bed availability
Lack of patient/family agreement with discharge plan
Patient B53‐year‐old white man2.973110.4423Nursing facility rejection of the patient
Lack of patient/family agreement with discharge plan
Complications with insurance coverage
Home care service delays
Patient C98‐year‐old Latina woman5.51295.2623Lack of patient/family agreement with discharge plan
Home care service delays
Complications with insurance coverage
Patient D83‐year‐old white woman8.94465.1513Nursing facility bed availability
Patient E93‐year‐old white woman9.05424.6416Nursing facility bed availability
Patient F87‐year‐old Latino man2.62114.206Nursing facility bed availability
Nursing facility rejection of the patient
Complications with insurance coverage
Patient G55‐year‐old white man5.66234.067Lack of patient/family agreement with discharge plan
Patient H40‐year‐old African American man6.2325'4.0114Nursing facility rejection of the patient
Nursing facility bed availability

Of the nonmedical cases, all but 1 patient had been seen by an MSVD social worker prior to hospital admission, though the social work referral may have been years prior to or unrelated to the current admission.

DISCUSSION

Almost half of long‐stay patients identified in this homebound population remained hospitalized in an urban academic medical center due to at least one, and often multiple, nonmedical factors. Nonmedical factors identified in this group are similar to those described in previous studies, particularly family and patient decision‐making and post‐hospital placement and care needs.5, 7 Although this pilot study was limited to a single‐site population, it is to our knowledge the first study to describe these factors in a homebound population, and may be able to guide future research and discussion on this topic.

This study used a risk‐adjusted LOS measure to determine long stay cases. Using the UHC Database allowed for a more accurate understanding of the contribution of nonmedical factors to LOS by accounting for hospitalizations that were numerically lengthy but medically appropriate for their respective DRG. The use of the LOS ratio also allows for standardized application of these data across academic health centers. In our sample, 50% of the patients classified as LOS outliers by the UHC Database (cases with LOS in the top percentile for their respective DRG) had nonmedical stays. Conventional strategies often dismiss outliers in analyses of patient LOS data. However, in doing so there is a missed opportunity to identify underlying reasons for their disproportionately long hospitalizations that may also be impacting the broader set of patients with similar nonmedical factors affecting LOS.

The 8 nonmedical stay patients spent a combined 136 days longer in the hospital than medically necessary due to a variety of nonmedical factors, and represented over half of the nonmedical stay group's total hospital days. Using a conservative estimate for cost per hospital day of $1770,16 the nonmedical days cost the hospital almost a quarter of a million dollars ($240,720). Because this figure only accounts for long‐stay patients, the actual costs attributable to nonmedical days for the homebound population in general may be higher.

The longest patient stays, whether attributable to medical or nonmedical factors, were more likely to result in discharge to a facility than the rest of the sample hospitalizations. Facility placement was the most common nonmedical factor contributing to long stays in this sample. In contrast, home carerelated factors contributed the least to nonmedical days. This finding highlights the need for hospital‐based physicians and other inpatient staff members to be aware that despite patient enrollment in an HBPC, the possibility for homebound patients to be discharged to a nursing facility remains significant. A decreasing number of skilled nursing beds across the United States may magnify this factor in long‐stay cases.17 Increased awareness of this possibility among inpatient staff can allow the team to address facility placement considerations early in the hospital stay, potentially decreasing nonmedical days.18

Seven of the 8 nonmedical stay patients had been referred to and seen by MSVD social workers before hospitalization, a high percentage relative to the general MSVD population, of which fewer than half are seen by a social worker during their enrollment in MSVD. This finding may suggest that this group of patients already exhibited difficult social circumstances before their hospital admission, yet the current referral‐based social work model at MSVD did not mitigate their high LOS. This finding further suggests that patient enrollment in an HBPC does not mitigate the risk of high LOS and prolonged nonmedical stays, and that involvement of inpatient practitioners remains a critical part of advanced discharge planning.

This pilot study found that 32% of all long‐stay hospital days were due to nonmedical factors, suggesting that these factors play a greater role in the homebound population than for general medical patients. A recent study at an academic medical center examined 3574 patient‐days on a general medicine service, and noted that 11% of all days were felt to be medically unnecessary by the treating hospitalists.19 Hospitalists are well situated to participate in and lead improvement efforts given their expertise in managing complex dispositions and advancing collaborative strategies for care of patients with high overall acuity.20 These efforts will be needed to target those patients at highest risk for prolonged LOS with the greatest social care needs. Because this study did not pilot strategies to reduce LOS, we cannot offer evidence‐based suggestions for an enhanced multidisciplinary approach or other avenues for improvement. However, we believe that the study findings provide the basis for future research to test strategies to reduce excess LOS by focusing on nonmedical factors and a multidisciplinary approach. This will become especially relevant as health care systems bear increasing financial responsibility for inefficient and/or unnecessary hospitalizations and readmissions.

The involvement of social work before hospitalization for most of the homebound population with prolonged hospitalization suggests a need for greater team‐based efforts across venues. Though hospital interdisciplinary rounds aim to increase collaboration and reduce LOS, costs, and readmissions, these rounds do not typically include outpatient care providers.21 Improved communication and collaboration between social work with both inpatient and outpatient care teams to address nonmedical issues contributing to long stays are likely to improve care and transitions, though rigorous studies examining specific communication models across venues are lacking. This study found that delay in nursing facility placement was the most common reason for prolonged hospitalization for long‐stay cases. This finding emphasizes the need for communication between inpatient and outpatient staff to convey prior conversations or preparations for placement, identify patients who need post‐discharge facility placement early in hospitalization, and prompt timely discussions with patients and families.

The finding that prolonged hospitalization for the homebound population was due to nonmedical factors for almost one‐half of patients with long hospital stays has important implications for policymakers and other key stakeholders. For example, accountable care organizations are being developed to align members of the health care sector to provide higher quality care in a more efficient manner. These study data suggest that this alignment should include hospitals, nursing homes, and home health care agencies to ensure that discharge delays are minimized and unnecessary societal costs are avoided. Future research will need to confirm and build upon these findings of nonmedical reasons for excessive LOS to further inform the process of implementation of health care reform measures. Recent plans to cut Medicaid funding to nursing homes may further limit bed availability, increasing the risk of prolonged LOS and related costs to the health care system. This potential concern highlights the importance of care coordination and communication between inpatient and outpatient care providers to proactively address nursing home placement needs before hospitalization occurs, and/or to identify alternative safe discharge plans if a previously homebound patient is hospitalized.

There are several limitations to this descriptive study. Admissions included in this analysis were only captured for those admitted to The Mount Sinai Hospital. While MSVD providers report that more than 90% of hospitalizations for MSVD patients occur at The Mount Sinai Hospital, patients may also be admitted to one of many New York City metropolitan area hospitals closer to the patient's residence. It is possible that additional factors contributing to high LOS might be revealed if these admissions were included in the analysis. The urban homebound population served by MSVD may have more access to supplementary home care services (e.g. home attendants, meal services) than populations in more rural and less service‐intensive areas. Thus, it may be difficult to generalize these findings to programs serving less urban constituencies or with more restrictive policies regarding home care services. Additionally, as New York registers one of the highest nursing facility occupancy rates (in 2008, 92.2% versus the national average of 82.9%), patients in other markets may face a shorter wait time for a bed, decreasing the number of nonmedical days attributable to nursing home bed supply.17 The small total number of long‐stay patients also prevented statistical analysis comparing those patients with the rest of the sample. This pilot study may inform the design of future studies that may be able to include multiple HBPC programs or study homebound patients over a longer period to increase sample size.

Identifying the significant contribution of nonmedical days to patient stay is an important initial step to avoiding costly and medically unnecessary days for the patient and the hospital. As has been demonstrated in other interdisciplinary efforts, increased collaboration among physicians, social workers, discharge planners, and other disciplines may help address current gaps in patient care with regard to LOS.20, 21 Future studies should determine which homebound patients are at highest risk for prolonged hospitalization due to nonmedical factors to help design focused strategies and interventions for this vulnerable population.

Acknowledgements

Funding: This work was supported in part by grant funds received by Katherine Ornstein and Theresa Soriano from The Fan Fox and Leslie R. Samuels Foundation, Inc.

Files
References
  1. Chen LM,Freitag MH,Franco M,Sullivan CD,Dickson C,Brancati FL.Natural history of late discharges from a general medical ward.J Hosp Med.2009;4:226233.
  2. Rifkin WD,Holmboe E,Scherer H,Sierra H.Comparison of hospitalists and nonhospitalists in inpatient length of stay adjusting for patient and physician characteristics.J Gen Intern Med.2004;19:11271132.
  3. Kaboli PJ,Barnett MJ,Rosenthal G.Associations with reduced length of stay and costs on an academic hospitalist service.Am J Manag Care.2004;10:561568.
  4. Evans RL,Hendricks RD,Lawrence‐Umlauf KV,Bishop DS.Timing of social work intervention and medical patient's length of hospital stay.Health Soc Work.1989;14:277282.
  5. Fillit H,Howe JL,Fulop G, et al.Studies of hospital social stays in the frail elderly and their relationship to the intensity of social work intervention.Soc Work Health Care.1992;18:122.
  6. Thomas SN,McGwin G,Rue LW.The financial impact of delayed discharge at a level I trauma center.J Trauma.2005;58:121125.
  7. Semke J,VanDerWeele T,Weatherley R.Delayed discharges for medical and surgical patients in an acute care hospital.Soc Work Health Care.1989;14:1531.
  8. Qiu WQ,Dean M,Liu T, et al.Physical and mental health of homebound older adults: an overlooked population.J Am Geriatr Soc.2010;58:24232428.
  9. American Academy of Home Care Physicians. House call fact sheet. Available at: http://www.aahcp.org/displaycommon.cfm?an=156:744749.
  10. Loengard AU,Boal J.Home care of the frail elderly.Clin Geriatr Med.2004;20:795807.
  11. Kripalani S,Jackson AT,Schnipper JL,Coleman EA.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2:314323.
  12. Smith KL,Ornstein K,Soriano T,Muller D,Boal J.A multidisciplinary program for delivering primary care to the underserved urban homebound: looking back, moving forward.J Am Geriatr Soc.2006;54:12831289.
  13. Ornstein K,Smith KL,Foer D,Lopez‐Cantor M,Soriano T.To the hospital and back home again: a nurse practitioner‐based transitional care program for the hospitalized homebound.J Am Geriatr Soc.2011;59:544551.
  14. University HealthSystems Consortium. About UHC. Available at: https://www.uhc.edu/12443.htm. Accessed July 18,2010.
  15. US Census Bureau Statistical Abstract of the United States,2010. Health and Nutrition, Table 170: New York. Available at: http://www.census.gov/compendia/statab/cats/health_nutrition.html. Accessed February 24,year="2011"2011.
  16. National Center for Health Statistics. Health, United States, 2009: with special feature on medical technology. Table 119: nursing homes, bed, residents, and occupancy rates by state: United States, selected years 1995–2008. http://www.cdc. gov/nchs/hus.htm. Accessed July 17,2010.
  17. Hou JW,Hollenberg J,Charlson ME.Can physicians' admission evaluation of patients' status help to identify patients requiring social work interventions?Soc Work Health Care.2001;33:1729.
  18. Kim CS,Hart AL,Paretti RF, et al.Excess hospitalization days in an academic medical center: perceptions of hospitalists and discharge planners.Am J Manag Care.2011;17:e34e42.
  19. Southern WN,Berger MA,Bellin EY,Hailpern SM,Arnsten JH.Hospitalist care and length‐of‐stay in patients requiring complex discharge planning and close clinical monitoring.Arch Intern Med.2007;167:18691874.
  20. O'Leary KJ,Haviley C,Slade ME,Shah HM,Lee J,Williams MV.Improving teamwork: impact of structured interdisciplinary rounds on a hospitalist unit.J Hosp Med.2011;6:8893.
Article PDF
Issue
Journal of Hospital Medicine - 7(2)
Publications
Page Number
73-78
Sections
Files
Files
Article PDF
Article PDF

In recent years, much attention has been paid to concerns regarding length of stay (LOS) and safety of hospital discharges.13 Yet studies conducted in a variety of populations suggest that long stays do not wholly reflect acute medical necessity, but may also be driven by nonmedical factors.46 In a study of frail elderly patients, nonmedical factors accounted for over half of patients' hospital stay days.5 Nonmedical factors may include the availability of community and outpatient resources, inadequate patient social support, disagreement with family and/or patient decision‐making, and post‐hospital placement and care needs.7

Homebound patients are at particular risk for long stays because they are typically frail, elderly, and medically complex.8 The United States homebound population numbers at least 2 million and is expected to increase to at least 3 million by the year 2020.9 This group is medically underserved, often only receiving care for medical emergencies, and represents a costly group of health care beneficiaries.10 Although homebound primary care (HBPC) programs are structured to provide coordinated medical and supportive care in the home, the clinical complexity of patients often requires hospitalization during times of acute illness.11

Navigating the discharge process for homebound patients can prove time‐consuming for inpatient physicians whose clinical obligations encompass ensuring safe care transitions between hospital and home.12 The lack of literature on the discharge needs of the homebound population provides little guidance for physicians and health systems seeking to safely transition homebound patients from the hospital to the home in a timely and efficient manner. We performed a pilot study of an urban homebound population cared for by a single academic homebound program to identify and describe nonmedical factors associated with prolonged hospitalization.

METHODS

This retrospective descriptive study included homebound patients cared for by The Mount Sinai Visiting Doctors Program (MSVD), a primary care program affiliated with The Mount Sinai Hospital. MSVD is the largest academic homebound primary care program in the United States. The structure and patient population of MSVD patients have been described previously.13 Briefly, the program employs 8 physicians, 2 nurse practitioners, and support personnel including 2 registered nurses, 4 social workers, and 4 clerical staff members to serve over 1000 homebound patients annually. To be enrolled in the program, patients must meet the Medicare definition of homebound (ie, they must be able to leave home only with great difficulty and for infrequent or short absences). Patients are referred from a variety of sources including emergency rooms, inpatient units, and local nursing and social service agencies. Physicians visit patients on average once every 2 months, but can make more frequent home visits when a clinical need arises. Thirty‐six percent of patients in the program are hospitalized at least once per year while they are under the MSVD's care.14 Patients in the MSVD are referred by their primary care physician to outpatient social work as needed for finite interventions, though not for ongoing case management; approximately one‐third of all MSVD patients have been seen by an MSVD social worker over a 1‐year period.14

All patients enrolled in MSVD discharged from The Mount Sinai Hospital in New York from January 1, 2007, to December 31, 2007, were evaluated for inclusion in this study. The MSVD clinical database was cross‐referenced with The Mount Sinai Hospital data system to maximize reliability of recorded admission and discharge dates. Discrepancies in dates were investigated and corrected by the authors. As the study focused on admissions rather than individual patients, repeat hospitalizations and factors contributing to long stays were included and considered separately. In the event of repeat hospitalizations, factors contributing to LOS were also assessed separately.

Using the University HealthSystems Consortium (UHC) Database, the selected discharges were analyzed for LOS data. The UHC Database contains data from The Mount Sinai Hospital and 106 other academic medical centers and 233 other affiliated hospitals, representing approximately 90% of the United States' nonprofit academic medical centers. UHC members submit clinical, financial, and administrative information for the purpose of facilitating comparative data analysis among institutions.15 The model assigns an expected LOS for each patient based on a 4‐step risk adjustment methodology that adjusts for variations in patient characteristics. The regression models consider a range of independent variables including patient age, sex, race, socioeconomic status, admission source, and comorbid conditions. The expected LOS value is used to produce an LOS ratio, which is the ratio of a patient's observed LOS to expected LOS. We compared LOS ratios for all patient discharges during the study period and determined the mean LOS ratio for the group. Long‐stay patients were defined using the UHC definition of an LOS ratio greater than 2 standard deviations above the mean. These patients were selected for analysis to examine factors contributing to their long stays.

The primary author conducted a chart review for the long‐stay patients. The date of medical readiness for discharge was defined as the date when no acute hospital care needs or pending procedures (eg, intravenous medication, transfusion, invasive and noninvasive testing, surgery) were documented by the attending physician, house officer, nurse practitioner, or physician assistant in the chart. Patients with a discharge immediately following determination of medical readiness were characterized as having a medical stay (eg, patient admitted for pneumonia and discharged home after 3 days once fever, leukocytosis, and symptoms improved with a prescription for remaining antibiotic course). Patients who were classified as medically ready for discharge yet remained additional days in the hospital were categorized as having a nonmedical component to their hospitalization and comprised the nonmedical stay group (eg, patient admitted for pneumonia with improved vital signs and symptoms after 3 days, but discharged home after 10 days awaiting approval of increased home health aide hours). The primary author reviewed cases (<5%) with coauthors when categorization of patient data was unclear from physician documentation in the patient's chart. Similar methodology and terminology have been used in previous studies examining the contribution of nonmedical factors to LOS.5, 7

While literature in other fields, such as social work, often characterize similar factors as social or social care factors, we use the term nonmedical to draw the distinction between factors that acutely reflect a patient's state of health and necessitate days spent in the hospital (eg, surgery, infection), in contrast to factors that are not direct contributors to the patient's current medical status (eg, post‐hospital placement). Factors contributing to nonmedical days were determined based on previous studies and categorized as follows: nursing facility bed availability, nursing facility rejection of the patient, complications with insurance coverage, lack of patient/family agreement with discharge plan, home care service delays, and other. The category other was included to identify and explore any unexpected or unique reasons for prolongation of hospitalization in this population. When multiple nonmedical factors were identified for a given hospitalization, all contributing factors were recorded.

Demographic, clinical, and discharge characteristics were extracted from the MSVD clinical database to qualitatively describe and compare the long‐stay hospitalizations to the remainder of the sample.

RESULTS

There were a total of 479 discharges of 267 unique MSVD patients from The Mount Sinai Hospital occurring from January 1, 2007, to December 31, 2007. During this 12‐month period, the average observed LOS for all admissions was 7.84 days, with a mean UHC LOS ratio of 1.23 (SD = 3.43). Seventeen admissions were identified as long‐stays, representing 3.5% of discharges. The 17 admissions represent 17 unique patients.

As shown in Table 1, the long‐stay group (n = 17) was slightly younger, more likely to be male, and had less dementia than the nonlong‐stay group (n = 462). There was a marked difference in the location of patient discharge; long‐stay patients were more than twice as likely to be discharged to a facility and less likely to be discharged home. There were no in‐hospital deaths in the long‐stay patient group during the time period studied.

Demographic, Clinical, and Discharge Characteristics for 2007 Hospitalizations According to Length of Stay
Characteristics*NonLong‐Stay Patients (n = 462)Long‐Stay Patients (n = 17)
  • NOTE: Characteristics describe all hospitalizations and include multiple discharges per patient.

  • Abbreviation: SD, standard deviation.

Mean age, years (SD)80 (15.6)74 (18.2)
Female sex69%47%
Race  
Caucasian27.1%29%
Black31.4%23.5%
Hispanic37.7%41.2%
Other2.4%5.9%
Has Medicaid68.1%70.6%
Dementia diagnosis42.9%29.4%
Depression diagnosis37.3%47.1%
Lives alone39.8%43.8%
Discharge  
Nursing/rehabilitation14.9%35.3%
Home78.3%64.7%
Death5.9%0%
Hospice0.9%0%

Of the 17 long‐stay patients, 8 (47%) remained in the hospital past the date they were determined to be medically ready for discharge and were defined as having a nonmedical component for the extension of their hospitalizations. The number of nonmedical days ranged from 6 to 34 days (mean, 17 days). Out of 428 total long‐stay patient days, 136 were nonmedical. This represented 31.8% of all long‐stay patient days, and 53% of the nonmedical group's total hospital days. The mean LOS ratio for the nonmedical cases was 6.04 (Table 2).

Medical Stay and Nonmedical Stay Length of Stay Ratios
 Medical Stay (n = 9)Nonmedical Stay (n = 8)
  • Abbreviation: LOS, length of stay.

LOS (days)19.217
LOS ratio5.076.04

Nine patients were defined as medical stay cases (ie, no nonmedical component contributing to the long hospitalization). The mean observed LOS was 19.2 days, and the mean LOS ratio for this group was 5.07 (Table 2). There were no significant differences between primary diagnosis‐related groups (DRGs) seen in the medical and nonmedical stay groups.

The most common reason for a nonmedical stay was nursing facility placement delays (Table 3), specifically related to lack of bed availability and facility rejection of the patient leading to prolonged time waiting for long‐term placement (n = 6). Other nonmedical factors contributing to LOS were lack of patient and/or family agreement with discharge plans (eg, disagreement among family members regarding caregiving responsibilities, goals of care, or patient refusal to be discharged on a particular day) (n = 4); complications with insurance coverage for facility placement or for home care (n = 3); and home care service delays, such as patient need for increased home care hours after discharge (n = 2). Of note, 5 of the 8 nonmedical stay cases had multiple factors contributing to patients' long stays. All delays were assigned to one of the a priori defined categories. There were no other or unexpected reasons identified.

Characteristics of Nonmedical Long‐Stay Patients
PatientDemographicsExpected LOS (days)Observed LOS (days)LOS RatioNo. of Nonmedical DaysNonmedical Stay Factors
  • Abbreviation: LOS, length of stay.

Patient A63‐year‐old white man4.564810.5334Nursing facility bed availability
Lack of patient/family agreement with discharge plan
Patient B53‐year‐old white man2.973110.4423Nursing facility rejection of the patient
Lack of patient/family agreement with discharge plan
Complications with insurance coverage
Home care service delays
Patient C98‐year‐old Latina woman5.51295.2623Lack of patient/family agreement with discharge plan
Home care service delays
Complications with insurance coverage
Patient D83‐year‐old white woman8.94465.1513Nursing facility bed availability
Patient E93‐year‐old white woman9.05424.6416Nursing facility bed availability
Patient F87‐year‐old Latino man2.62114.206Nursing facility bed availability
Nursing facility rejection of the patient
Complications with insurance coverage
Patient G55‐year‐old white man5.66234.067Lack of patient/family agreement with discharge plan
Patient H40‐year‐old African American man6.2325'4.0114Nursing facility rejection of the patient
Nursing facility bed availability

Of the nonmedical cases, all but 1 patient had been seen by an MSVD social worker prior to hospital admission, though the social work referral may have been years prior to or unrelated to the current admission.

DISCUSSION

Almost half of long‐stay patients identified in this homebound population remained hospitalized in an urban academic medical center due to at least one, and often multiple, nonmedical factors. Nonmedical factors identified in this group are similar to those described in previous studies, particularly family and patient decision‐making and post‐hospital placement and care needs.5, 7 Although this pilot study was limited to a single‐site population, it is to our knowledge the first study to describe these factors in a homebound population, and may be able to guide future research and discussion on this topic.

This study used a risk‐adjusted LOS measure to determine long stay cases. Using the UHC Database allowed for a more accurate understanding of the contribution of nonmedical factors to LOS by accounting for hospitalizations that were numerically lengthy but medically appropriate for their respective DRG. The use of the LOS ratio also allows for standardized application of these data across academic health centers. In our sample, 50% of the patients classified as LOS outliers by the UHC Database (cases with LOS in the top percentile for their respective DRG) had nonmedical stays. Conventional strategies often dismiss outliers in analyses of patient LOS data. However, in doing so there is a missed opportunity to identify underlying reasons for their disproportionately long hospitalizations that may also be impacting the broader set of patients with similar nonmedical factors affecting LOS.

The 8 nonmedical stay patients spent a combined 136 days longer in the hospital than medically necessary due to a variety of nonmedical factors, and represented over half of the nonmedical stay group's total hospital days. Using a conservative estimate for cost per hospital day of $1770,16 the nonmedical days cost the hospital almost a quarter of a million dollars ($240,720). Because this figure only accounts for long‐stay patients, the actual costs attributable to nonmedical days for the homebound population in general may be higher.

The longest patient stays, whether attributable to medical or nonmedical factors, were more likely to result in discharge to a facility than the rest of the sample hospitalizations. Facility placement was the most common nonmedical factor contributing to long stays in this sample. In contrast, home carerelated factors contributed the least to nonmedical days. This finding highlights the need for hospital‐based physicians and other inpatient staff members to be aware that despite patient enrollment in an HBPC, the possibility for homebound patients to be discharged to a nursing facility remains significant. A decreasing number of skilled nursing beds across the United States may magnify this factor in long‐stay cases.17 Increased awareness of this possibility among inpatient staff can allow the team to address facility placement considerations early in the hospital stay, potentially decreasing nonmedical days.18

Seven of the 8 nonmedical stay patients had been referred to and seen by MSVD social workers before hospitalization, a high percentage relative to the general MSVD population, of which fewer than half are seen by a social worker during their enrollment in MSVD. This finding may suggest that this group of patients already exhibited difficult social circumstances before their hospital admission, yet the current referral‐based social work model at MSVD did not mitigate their high LOS. This finding further suggests that patient enrollment in an HBPC does not mitigate the risk of high LOS and prolonged nonmedical stays, and that involvement of inpatient practitioners remains a critical part of advanced discharge planning.

This pilot study found that 32% of all long‐stay hospital days were due to nonmedical factors, suggesting that these factors play a greater role in the homebound population than for general medical patients. A recent study at an academic medical center examined 3574 patient‐days on a general medicine service, and noted that 11% of all days were felt to be medically unnecessary by the treating hospitalists.19 Hospitalists are well situated to participate in and lead improvement efforts given their expertise in managing complex dispositions and advancing collaborative strategies for care of patients with high overall acuity.20 These efforts will be needed to target those patients at highest risk for prolonged LOS with the greatest social care needs. Because this study did not pilot strategies to reduce LOS, we cannot offer evidence‐based suggestions for an enhanced multidisciplinary approach or other avenues for improvement. However, we believe that the study findings provide the basis for future research to test strategies to reduce excess LOS by focusing on nonmedical factors and a multidisciplinary approach. This will become especially relevant as health care systems bear increasing financial responsibility for inefficient and/or unnecessary hospitalizations and readmissions.

The involvement of social work before hospitalization for most of the homebound population with prolonged hospitalization suggests a need for greater team‐based efforts across venues. Though hospital interdisciplinary rounds aim to increase collaboration and reduce LOS, costs, and readmissions, these rounds do not typically include outpatient care providers.21 Improved communication and collaboration between social work with both inpatient and outpatient care teams to address nonmedical issues contributing to long stays are likely to improve care and transitions, though rigorous studies examining specific communication models across venues are lacking. This study found that delay in nursing facility placement was the most common reason for prolonged hospitalization for long‐stay cases. This finding emphasizes the need for communication between inpatient and outpatient staff to convey prior conversations or preparations for placement, identify patients who need post‐discharge facility placement early in hospitalization, and prompt timely discussions with patients and families.

The finding that prolonged hospitalization for the homebound population was due to nonmedical factors for almost one‐half of patients with long hospital stays has important implications for policymakers and other key stakeholders. For example, accountable care organizations are being developed to align members of the health care sector to provide higher quality care in a more efficient manner. These study data suggest that this alignment should include hospitals, nursing homes, and home health care agencies to ensure that discharge delays are minimized and unnecessary societal costs are avoided. Future research will need to confirm and build upon these findings of nonmedical reasons for excessive LOS to further inform the process of implementation of health care reform measures. Recent plans to cut Medicaid funding to nursing homes may further limit bed availability, increasing the risk of prolonged LOS and related costs to the health care system. This potential concern highlights the importance of care coordination and communication between inpatient and outpatient care providers to proactively address nursing home placement needs before hospitalization occurs, and/or to identify alternative safe discharge plans if a previously homebound patient is hospitalized.

There are several limitations to this descriptive study. Admissions included in this analysis were only captured for those admitted to The Mount Sinai Hospital. While MSVD providers report that more than 90% of hospitalizations for MSVD patients occur at The Mount Sinai Hospital, patients may also be admitted to one of many New York City metropolitan area hospitals closer to the patient's residence. It is possible that additional factors contributing to high LOS might be revealed if these admissions were included in the analysis. The urban homebound population served by MSVD may have more access to supplementary home care services (e.g. home attendants, meal services) than populations in more rural and less service‐intensive areas. Thus, it may be difficult to generalize these findings to programs serving less urban constituencies or with more restrictive policies regarding home care services. Additionally, as New York registers one of the highest nursing facility occupancy rates (in 2008, 92.2% versus the national average of 82.9%), patients in other markets may face a shorter wait time for a bed, decreasing the number of nonmedical days attributable to nursing home bed supply.17 The small total number of long‐stay patients also prevented statistical analysis comparing those patients with the rest of the sample. This pilot study may inform the design of future studies that may be able to include multiple HBPC programs or study homebound patients over a longer period to increase sample size.

Identifying the significant contribution of nonmedical days to patient stay is an important initial step to avoiding costly and medically unnecessary days for the patient and the hospital. As has been demonstrated in other interdisciplinary efforts, increased collaboration among physicians, social workers, discharge planners, and other disciplines may help address current gaps in patient care with regard to LOS.20, 21 Future studies should determine which homebound patients are at highest risk for prolonged hospitalization due to nonmedical factors to help design focused strategies and interventions for this vulnerable population.

Acknowledgements

Funding: This work was supported in part by grant funds received by Katherine Ornstein and Theresa Soriano from The Fan Fox and Leslie R. Samuels Foundation, Inc.

In recent years, much attention has been paid to concerns regarding length of stay (LOS) and safety of hospital discharges.13 Yet studies conducted in a variety of populations suggest that long stays do not wholly reflect acute medical necessity, but may also be driven by nonmedical factors.46 In a study of frail elderly patients, nonmedical factors accounted for over half of patients' hospital stay days.5 Nonmedical factors may include the availability of community and outpatient resources, inadequate patient social support, disagreement with family and/or patient decision‐making, and post‐hospital placement and care needs.7

Homebound patients are at particular risk for long stays because they are typically frail, elderly, and medically complex.8 The United States homebound population numbers at least 2 million and is expected to increase to at least 3 million by the year 2020.9 This group is medically underserved, often only receiving care for medical emergencies, and represents a costly group of health care beneficiaries.10 Although homebound primary care (HBPC) programs are structured to provide coordinated medical and supportive care in the home, the clinical complexity of patients often requires hospitalization during times of acute illness.11

Navigating the discharge process for homebound patients can prove time‐consuming for inpatient physicians whose clinical obligations encompass ensuring safe care transitions between hospital and home.12 The lack of literature on the discharge needs of the homebound population provides little guidance for physicians and health systems seeking to safely transition homebound patients from the hospital to the home in a timely and efficient manner. We performed a pilot study of an urban homebound population cared for by a single academic homebound program to identify and describe nonmedical factors associated with prolonged hospitalization.

METHODS

This retrospective descriptive study included homebound patients cared for by The Mount Sinai Visiting Doctors Program (MSVD), a primary care program affiliated with The Mount Sinai Hospital. MSVD is the largest academic homebound primary care program in the United States. The structure and patient population of MSVD patients have been described previously.13 Briefly, the program employs 8 physicians, 2 nurse practitioners, and support personnel including 2 registered nurses, 4 social workers, and 4 clerical staff members to serve over 1000 homebound patients annually. To be enrolled in the program, patients must meet the Medicare definition of homebound (ie, they must be able to leave home only with great difficulty and for infrequent or short absences). Patients are referred from a variety of sources including emergency rooms, inpatient units, and local nursing and social service agencies. Physicians visit patients on average once every 2 months, but can make more frequent home visits when a clinical need arises. Thirty‐six percent of patients in the program are hospitalized at least once per year while they are under the MSVD's care.14 Patients in the MSVD are referred by their primary care physician to outpatient social work as needed for finite interventions, though not for ongoing case management; approximately one‐third of all MSVD patients have been seen by an MSVD social worker over a 1‐year period.14

All patients enrolled in MSVD discharged from The Mount Sinai Hospital in New York from January 1, 2007, to December 31, 2007, were evaluated for inclusion in this study. The MSVD clinical database was cross‐referenced with The Mount Sinai Hospital data system to maximize reliability of recorded admission and discharge dates. Discrepancies in dates were investigated and corrected by the authors. As the study focused on admissions rather than individual patients, repeat hospitalizations and factors contributing to long stays were included and considered separately. In the event of repeat hospitalizations, factors contributing to LOS were also assessed separately.

Using the University HealthSystems Consortium (UHC) Database, the selected discharges were analyzed for LOS data. The UHC Database contains data from The Mount Sinai Hospital and 106 other academic medical centers and 233 other affiliated hospitals, representing approximately 90% of the United States' nonprofit academic medical centers. UHC members submit clinical, financial, and administrative information for the purpose of facilitating comparative data analysis among institutions.15 The model assigns an expected LOS for each patient based on a 4‐step risk adjustment methodology that adjusts for variations in patient characteristics. The regression models consider a range of independent variables including patient age, sex, race, socioeconomic status, admission source, and comorbid conditions. The expected LOS value is used to produce an LOS ratio, which is the ratio of a patient's observed LOS to expected LOS. We compared LOS ratios for all patient discharges during the study period and determined the mean LOS ratio for the group. Long‐stay patients were defined using the UHC definition of an LOS ratio greater than 2 standard deviations above the mean. These patients were selected for analysis to examine factors contributing to their long stays.

The primary author conducted a chart review for the long‐stay patients. The date of medical readiness for discharge was defined as the date when no acute hospital care needs or pending procedures (eg, intravenous medication, transfusion, invasive and noninvasive testing, surgery) were documented by the attending physician, house officer, nurse practitioner, or physician assistant in the chart. Patients with a discharge immediately following determination of medical readiness were characterized as having a medical stay (eg, patient admitted for pneumonia and discharged home after 3 days once fever, leukocytosis, and symptoms improved with a prescription for remaining antibiotic course). Patients who were classified as medically ready for discharge yet remained additional days in the hospital were categorized as having a nonmedical component to their hospitalization and comprised the nonmedical stay group (eg, patient admitted for pneumonia with improved vital signs and symptoms after 3 days, but discharged home after 10 days awaiting approval of increased home health aide hours). The primary author reviewed cases (<5%) with coauthors when categorization of patient data was unclear from physician documentation in the patient's chart. Similar methodology and terminology have been used in previous studies examining the contribution of nonmedical factors to LOS.5, 7

While literature in other fields, such as social work, often characterize similar factors as social or social care factors, we use the term nonmedical to draw the distinction between factors that acutely reflect a patient's state of health and necessitate days spent in the hospital (eg, surgery, infection), in contrast to factors that are not direct contributors to the patient's current medical status (eg, post‐hospital placement). Factors contributing to nonmedical days were determined based on previous studies and categorized as follows: nursing facility bed availability, nursing facility rejection of the patient, complications with insurance coverage, lack of patient/family agreement with discharge plan, home care service delays, and other. The category other was included to identify and explore any unexpected or unique reasons for prolongation of hospitalization in this population. When multiple nonmedical factors were identified for a given hospitalization, all contributing factors were recorded.

Demographic, clinical, and discharge characteristics were extracted from the MSVD clinical database to qualitatively describe and compare the long‐stay hospitalizations to the remainder of the sample.

RESULTS

There were a total of 479 discharges of 267 unique MSVD patients from The Mount Sinai Hospital occurring from January 1, 2007, to December 31, 2007. During this 12‐month period, the average observed LOS for all admissions was 7.84 days, with a mean UHC LOS ratio of 1.23 (SD = 3.43). Seventeen admissions were identified as long‐stays, representing 3.5% of discharges. The 17 admissions represent 17 unique patients.

As shown in Table 1, the long‐stay group (n = 17) was slightly younger, more likely to be male, and had less dementia than the nonlong‐stay group (n = 462). There was a marked difference in the location of patient discharge; long‐stay patients were more than twice as likely to be discharged to a facility and less likely to be discharged home. There were no in‐hospital deaths in the long‐stay patient group during the time period studied.

Demographic, Clinical, and Discharge Characteristics for 2007 Hospitalizations According to Length of Stay
Characteristics*NonLong‐Stay Patients (n = 462)Long‐Stay Patients (n = 17)
  • NOTE: Characteristics describe all hospitalizations and include multiple discharges per patient.

  • Abbreviation: SD, standard deviation.

Mean age, years (SD)80 (15.6)74 (18.2)
Female sex69%47%
Race  
Caucasian27.1%29%
Black31.4%23.5%
Hispanic37.7%41.2%
Other2.4%5.9%
Has Medicaid68.1%70.6%
Dementia diagnosis42.9%29.4%
Depression diagnosis37.3%47.1%
Lives alone39.8%43.8%
Discharge  
Nursing/rehabilitation14.9%35.3%
Home78.3%64.7%
Death5.9%0%
Hospice0.9%0%

Of the 17 long‐stay patients, 8 (47%) remained in the hospital past the date they were determined to be medically ready for discharge and were defined as having a nonmedical component for the extension of their hospitalizations. The number of nonmedical days ranged from 6 to 34 days (mean, 17 days). Out of 428 total long‐stay patient days, 136 were nonmedical. This represented 31.8% of all long‐stay patient days, and 53% of the nonmedical group's total hospital days. The mean LOS ratio for the nonmedical cases was 6.04 (Table 2).

Medical Stay and Nonmedical Stay Length of Stay Ratios
 Medical Stay (n = 9)Nonmedical Stay (n = 8)
  • Abbreviation: LOS, length of stay.

LOS (days)19.217
LOS ratio5.076.04

Nine patients were defined as medical stay cases (ie, no nonmedical component contributing to the long hospitalization). The mean observed LOS was 19.2 days, and the mean LOS ratio for this group was 5.07 (Table 2). There were no significant differences between primary diagnosis‐related groups (DRGs) seen in the medical and nonmedical stay groups.

The most common reason for a nonmedical stay was nursing facility placement delays (Table 3), specifically related to lack of bed availability and facility rejection of the patient leading to prolonged time waiting for long‐term placement (n = 6). Other nonmedical factors contributing to LOS were lack of patient and/or family agreement with discharge plans (eg, disagreement among family members regarding caregiving responsibilities, goals of care, or patient refusal to be discharged on a particular day) (n = 4); complications with insurance coverage for facility placement or for home care (n = 3); and home care service delays, such as patient need for increased home care hours after discharge (n = 2). Of note, 5 of the 8 nonmedical stay cases had multiple factors contributing to patients' long stays. All delays were assigned to one of the a priori defined categories. There were no other or unexpected reasons identified.

Characteristics of Nonmedical Long‐Stay Patients
PatientDemographicsExpected LOS (days)Observed LOS (days)LOS RatioNo. of Nonmedical DaysNonmedical Stay Factors
  • Abbreviation: LOS, length of stay.

Patient A63‐year‐old white man4.564810.5334Nursing facility bed availability
Lack of patient/family agreement with discharge plan
Patient B53‐year‐old white man2.973110.4423Nursing facility rejection of the patient
Lack of patient/family agreement with discharge plan
Complications with insurance coverage
Home care service delays
Patient C98‐year‐old Latina woman5.51295.2623Lack of patient/family agreement with discharge plan
Home care service delays
Complications with insurance coverage
Patient D83‐year‐old white woman8.94465.1513Nursing facility bed availability
Patient E93‐year‐old white woman9.05424.6416Nursing facility bed availability
Patient F87‐year‐old Latino man2.62114.206Nursing facility bed availability
Nursing facility rejection of the patient
Complications with insurance coverage
Patient G55‐year‐old white man5.66234.067Lack of patient/family agreement with discharge plan
Patient H40‐year‐old African American man6.2325'4.0114Nursing facility rejection of the patient
Nursing facility bed availability

Of the nonmedical cases, all but 1 patient had been seen by an MSVD social worker prior to hospital admission, though the social work referral may have been years prior to or unrelated to the current admission.

DISCUSSION

Almost half of long‐stay patients identified in this homebound population remained hospitalized in an urban academic medical center due to at least one, and often multiple, nonmedical factors. Nonmedical factors identified in this group are similar to those described in previous studies, particularly family and patient decision‐making and post‐hospital placement and care needs.5, 7 Although this pilot study was limited to a single‐site population, it is to our knowledge the first study to describe these factors in a homebound population, and may be able to guide future research and discussion on this topic.

This study used a risk‐adjusted LOS measure to determine long stay cases. Using the UHC Database allowed for a more accurate understanding of the contribution of nonmedical factors to LOS by accounting for hospitalizations that were numerically lengthy but medically appropriate for their respective DRG. The use of the LOS ratio also allows for standardized application of these data across academic health centers. In our sample, 50% of the patients classified as LOS outliers by the UHC Database (cases with LOS in the top percentile for their respective DRG) had nonmedical stays. Conventional strategies often dismiss outliers in analyses of patient LOS data. However, in doing so there is a missed opportunity to identify underlying reasons for their disproportionately long hospitalizations that may also be impacting the broader set of patients with similar nonmedical factors affecting LOS.

The 8 nonmedical stay patients spent a combined 136 days longer in the hospital than medically necessary due to a variety of nonmedical factors, and represented over half of the nonmedical stay group's total hospital days. Using a conservative estimate for cost per hospital day of $1770,16 the nonmedical days cost the hospital almost a quarter of a million dollars ($240,720). Because this figure only accounts for long‐stay patients, the actual costs attributable to nonmedical days for the homebound population in general may be higher.

The longest patient stays, whether attributable to medical or nonmedical factors, were more likely to result in discharge to a facility than the rest of the sample hospitalizations. Facility placement was the most common nonmedical factor contributing to long stays in this sample. In contrast, home carerelated factors contributed the least to nonmedical days. This finding highlights the need for hospital‐based physicians and other inpatient staff members to be aware that despite patient enrollment in an HBPC, the possibility for homebound patients to be discharged to a nursing facility remains significant. A decreasing number of skilled nursing beds across the United States may magnify this factor in long‐stay cases.17 Increased awareness of this possibility among inpatient staff can allow the team to address facility placement considerations early in the hospital stay, potentially decreasing nonmedical days.18

Seven of the 8 nonmedical stay patients had been referred to and seen by MSVD social workers before hospitalization, a high percentage relative to the general MSVD population, of which fewer than half are seen by a social worker during their enrollment in MSVD. This finding may suggest that this group of patients already exhibited difficult social circumstances before their hospital admission, yet the current referral‐based social work model at MSVD did not mitigate their high LOS. This finding further suggests that patient enrollment in an HBPC does not mitigate the risk of high LOS and prolonged nonmedical stays, and that involvement of inpatient practitioners remains a critical part of advanced discharge planning.

This pilot study found that 32% of all long‐stay hospital days were due to nonmedical factors, suggesting that these factors play a greater role in the homebound population than for general medical patients. A recent study at an academic medical center examined 3574 patient‐days on a general medicine service, and noted that 11% of all days were felt to be medically unnecessary by the treating hospitalists.19 Hospitalists are well situated to participate in and lead improvement efforts given their expertise in managing complex dispositions and advancing collaborative strategies for care of patients with high overall acuity.20 These efforts will be needed to target those patients at highest risk for prolonged LOS with the greatest social care needs. Because this study did not pilot strategies to reduce LOS, we cannot offer evidence‐based suggestions for an enhanced multidisciplinary approach or other avenues for improvement. However, we believe that the study findings provide the basis for future research to test strategies to reduce excess LOS by focusing on nonmedical factors and a multidisciplinary approach. This will become especially relevant as health care systems bear increasing financial responsibility for inefficient and/or unnecessary hospitalizations and readmissions.

The involvement of social work before hospitalization for most of the homebound population with prolonged hospitalization suggests a need for greater team‐based efforts across venues. Though hospital interdisciplinary rounds aim to increase collaboration and reduce LOS, costs, and readmissions, these rounds do not typically include outpatient care providers.21 Improved communication and collaboration between social work with both inpatient and outpatient care teams to address nonmedical issues contributing to long stays are likely to improve care and transitions, though rigorous studies examining specific communication models across venues are lacking. This study found that delay in nursing facility placement was the most common reason for prolonged hospitalization for long‐stay cases. This finding emphasizes the need for communication between inpatient and outpatient staff to convey prior conversations or preparations for placement, identify patients who need post‐discharge facility placement early in hospitalization, and prompt timely discussions with patients and families.

The finding that prolonged hospitalization for the homebound population was due to nonmedical factors for almost one‐half of patients with long hospital stays has important implications for policymakers and other key stakeholders. For example, accountable care organizations are being developed to align members of the health care sector to provide higher quality care in a more efficient manner. These study data suggest that this alignment should include hospitals, nursing homes, and home health care agencies to ensure that discharge delays are minimized and unnecessary societal costs are avoided. Future research will need to confirm and build upon these findings of nonmedical reasons for excessive LOS to further inform the process of implementation of health care reform measures. Recent plans to cut Medicaid funding to nursing homes may further limit bed availability, increasing the risk of prolonged LOS and related costs to the health care system. This potential concern highlights the importance of care coordination and communication between inpatient and outpatient care providers to proactively address nursing home placement needs before hospitalization occurs, and/or to identify alternative safe discharge plans if a previously homebound patient is hospitalized.

There are several limitations to this descriptive study. Admissions included in this analysis were only captured for those admitted to The Mount Sinai Hospital. While MSVD providers report that more than 90% of hospitalizations for MSVD patients occur at The Mount Sinai Hospital, patients may also be admitted to one of many New York City metropolitan area hospitals closer to the patient's residence. It is possible that additional factors contributing to high LOS might be revealed if these admissions were included in the analysis. The urban homebound population served by MSVD may have more access to supplementary home care services (e.g. home attendants, meal services) than populations in more rural and less service‐intensive areas. Thus, it may be difficult to generalize these findings to programs serving less urban constituencies or with more restrictive policies regarding home care services. Additionally, as New York registers one of the highest nursing facility occupancy rates (in 2008, 92.2% versus the national average of 82.9%), patients in other markets may face a shorter wait time for a bed, decreasing the number of nonmedical days attributable to nursing home bed supply.17 The small total number of long‐stay patients also prevented statistical analysis comparing those patients with the rest of the sample. This pilot study may inform the design of future studies that may be able to include multiple HBPC programs or study homebound patients over a longer period to increase sample size.

Identifying the significant contribution of nonmedical days to patient stay is an important initial step to avoiding costly and medically unnecessary days for the patient and the hospital. As has been demonstrated in other interdisciplinary efforts, increased collaboration among physicians, social workers, discharge planners, and other disciplines may help address current gaps in patient care with regard to LOS.20, 21 Future studies should determine which homebound patients are at highest risk for prolonged hospitalization due to nonmedical factors to help design focused strategies and interventions for this vulnerable population.

Acknowledgements

Funding: This work was supported in part by grant funds received by Katherine Ornstein and Theresa Soriano from The Fan Fox and Leslie R. Samuels Foundation, Inc.

References
  1. Chen LM,Freitag MH,Franco M,Sullivan CD,Dickson C,Brancati FL.Natural history of late discharges from a general medical ward.J Hosp Med.2009;4:226233.
  2. Rifkin WD,Holmboe E,Scherer H,Sierra H.Comparison of hospitalists and nonhospitalists in inpatient length of stay adjusting for patient and physician characteristics.J Gen Intern Med.2004;19:11271132.
  3. Kaboli PJ,Barnett MJ,Rosenthal G.Associations with reduced length of stay and costs on an academic hospitalist service.Am J Manag Care.2004;10:561568.
  4. Evans RL,Hendricks RD,Lawrence‐Umlauf KV,Bishop DS.Timing of social work intervention and medical patient's length of hospital stay.Health Soc Work.1989;14:277282.
  5. Fillit H,Howe JL,Fulop G, et al.Studies of hospital social stays in the frail elderly and their relationship to the intensity of social work intervention.Soc Work Health Care.1992;18:122.
  6. Thomas SN,McGwin G,Rue LW.The financial impact of delayed discharge at a level I trauma center.J Trauma.2005;58:121125.
  7. Semke J,VanDerWeele T,Weatherley R.Delayed discharges for medical and surgical patients in an acute care hospital.Soc Work Health Care.1989;14:1531.
  8. Qiu WQ,Dean M,Liu T, et al.Physical and mental health of homebound older adults: an overlooked population.J Am Geriatr Soc.2010;58:24232428.
  9. American Academy of Home Care Physicians. House call fact sheet. Available at: http://www.aahcp.org/displaycommon.cfm?an=156:744749.
  10. Loengard AU,Boal J.Home care of the frail elderly.Clin Geriatr Med.2004;20:795807.
  11. Kripalani S,Jackson AT,Schnipper JL,Coleman EA.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2:314323.
  12. Smith KL,Ornstein K,Soriano T,Muller D,Boal J.A multidisciplinary program for delivering primary care to the underserved urban homebound: looking back, moving forward.J Am Geriatr Soc.2006;54:12831289.
  13. Ornstein K,Smith KL,Foer D,Lopez‐Cantor M,Soriano T.To the hospital and back home again: a nurse practitioner‐based transitional care program for the hospitalized homebound.J Am Geriatr Soc.2011;59:544551.
  14. University HealthSystems Consortium. About UHC. Available at: https://www.uhc.edu/12443.htm. Accessed July 18,2010.
  15. US Census Bureau Statistical Abstract of the United States,2010. Health and Nutrition, Table 170: New York. Available at: http://www.census.gov/compendia/statab/cats/health_nutrition.html. Accessed February 24,year="2011"2011.
  16. National Center for Health Statistics. Health, United States, 2009: with special feature on medical technology. Table 119: nursing homes, bed, residents, and occupancy rates by state: United States, selected years 1995–2008. http://www.cdc. gov/nchs/hus.htm. Accessed July 17,2010.
  17. Hou JW,Hollenberg J,Charlson ME.Can physicians' admission evaluation of patients' status help to identify patients requiring social work interventions?Soc Work Health Care.2001;33:1729.
  18. Kim CS,Hart AL,Paretti RF, et al.Excess hospitalization days in an academic medical center: perceptions of hospitalists and discharge planners.Am J Manag Care.2011;17:e34e42.
  19. Southern WN,Berger MA,Bellin EY,Hailpern SM,Arnsten JH.Hospitalist care and length‐of‐stay in patients requiring complex discharge planning and close clinical monitoring.Arch Intern Med.2007;167:18691874.
  20. O'Leary KJ,Haviley C,Slade ME,Shah HM,Lee J,Williams MV.Improving teamwork: impact of structured interdisciplinary rounds on a hospitalist unit.J Hosp Med.2011;6:8893.
References
  1. Chen LM,Freitag MH,Franco M,Sullivan CD,Dickson C,Brancati FL.Natural history of late discharges from a general medical ward.J Hosp Med.2009;4:226233.
  2. Rifkin WD,Holmboe E,Scherer H,Sierra H.Comparison of hospitalists and nonhospitalists in inpatient length of stay adjusting for patient and physician characteristics.J Gen Intern Med.2004;19:11271132.
  3. Kaboli PJ,Barnett MJ,Rosenthal G.Associations with reduced length of stay and costs on an academic hospitalist service.Am J Manag Care.2004;10:561568.
  4. Evans RL,Hendricks RD,Lawrence‐Umlauf KV,Bishop DS.Timing of social work intervention and medical patient's length of hospital stay.Health Soc Work.1989;14:277282.
  5. Fillit H,Howe JL,Fulop G, et al.Studies of hospital social stays in the frail elderly and their relationship to the intensity of social work intervention.Soc Work Health Care.1992;18:122.
  6. Thomas SN,McGwin G,Rue LW.The financial impact of delayed discharge at a level I trauma center.J Trauma.2005;58:121125.
  7. Semke J,VanDerWeele T,Weatherley R.Delayed discharges for medical and surgical patients in an acute care hospital.Soc Work Health Care.1989;14:1531.
  8. Qiu WQ,Dean M,Liu T, et al.Physical and mental health of homebound older adults: an overlooked population.J Am Geriatr Soc.2010;58:24232428.
  9. American Academy of Home Care Physicians. House call fact sheet. Available at: http://www.aahcp.org/displaycommon.cfm?an=156:744749.
  10. Loengard AU,Boal J.Home care of the frail elderly.Clin Geriatr Med.2004;20:795807.
  11. Kripalani S,Jackson AT,Schnipper JL,Coleman EA.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2:314323.
  12. Smith KL,Ornstein K,Soriano T,Muller D,Boal J.A multidisciplinary program for delivering primary care to the underserved urban homebound: looking back, moving forward.J Am Geriatr Soc.2006;54:12831289.
  13. Ornstein K,Smith KL,Foer D,Lopez‐Cantor M,Soriano T.To the hospital and back home again: a nurse practitioner‐based transitional care program for the hospitalized homebound.J Am Geriatr Soc.2011;59:544551.
  14. University HealthSystems Consortium. About UHC. Available at: https://www.uhc.edu/12443.htm. Accessed July 18,2010.
  15. US Census Bureau Statistical Abstract of the United States,2010. Health and Nutrition, Table 170: New York. Available at: http://www.census.gov/compendia/statab/cats/health_nutrition.html. Accessed February 24,year="2011"2011.
  16. National Center for Health Statistics. Health, United States, 2009: with special feature on medical technology. Table 119: nursing homes, bed, residents, and occupancy rates by state: United States, selected years 1995–2008. http://www.cdc. gov/nchs/hus.htm. Accessed July 17,2010.
  17. Hou JW,Hollenberg J,Charlson ME.Can physicians' admission evaluation of patients' status help to identify patients requiring social work interventions?Soc Work Health Care.2001;33:1729.
  18. Kim CS,Hart AL,Paretti RF, et al.Excess hospitalization days in an academic medical center: perceptions of hospitalists and discharge planners.Am J Manag Care.2011;17:e34e42.
  19. Southern WN,Berger MA,Bellin EY,Hailpern SM,Arnsten JH.Hospitalist care and length‐of‐stay in patients requiring complex discharge planning and close clinical monitoring.Arch Intern Med.2007;167:18691874.
  20. O'Leary KJ,Haviley C,Slade ME,Shah HM,Lee J,Williams MV.Improving teamwork: impact of structured interdisciplinary rounds on a hospitalist unit.J Hosp Med.2011;6:8893.
Issue
Journal of Hospital Medicine - 7(2)
Issue
Journal of Hospital Medicine - 7(2)
Page Number
73-78
Page Number
73-78
Publications
Publications
Article Type
Display Headline
Nonmedical factors associated with prolonged hospital length of stay in an urban homebound population
Display Headline
Nonmedical factors associated with prolonged hospital length of stay in an urban homebound population
Sections
Article Source

Copyright © 2011 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Mount Sinai Visiting Doctors Program, The Mount Sinai Hospital, Box 1216, 17 East 102nd Street, New York, NY 10029
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media
Media Files

Care Model for ED Boarders

Article Type
Changed
Sun, 05/28/2017 - 20:20
Display Headline
A model of a hospitalist role in the care of admitted patients in the emergency department

Emergency Department (ED) overcrowding has become an important problem in North American hospitals.13 A national survey identified the prolonged length of stay of admitted patients in the ED as the most frequent reason for overcrowding.4 This complex problem occurs when hospital inpatient census increases and prevents admitted patients from being assigned and transported to hospital beds in a timely manner.5 The practice of holding admitted patients in the ED, known as boarding, is typically defined as the length of stay (LOS) in ED beginning 2 hours after the time of admission to the time of transfer to the wards.

In a study of daily mean ED LOS, Rathlev et al.6 concluded that a 5% increase in hospital occupancy resulted in 14 hours of holding time for all patients in the ED, and an observational study found that when hospital occupancy exceeds a threshold of 90%, the ED LOS for admitted patients correspondingly increased.7 Thus, efforts to decrease overcrowding will need to address both ED and hospital throughput and LOS. Most importantly, overcrowding has important consequences on physician and patient satisfaction and the quality of patient care.811

Between 1995 and 2005, ED visits rose 20% from 96.5 million to 115.3 million visits annually, while the number of hospital EDs decreased from 4176 to 3795, making an overall 7% increase in ED utilization rate.12 Similarly, there was a 12% increase in the total inpatient admissions for all registered hospitals in the United States from 31 million in 1995 to 35.3 million in 2005.13 However, despite this increase in demand of ED utilization and inpatient admissions, there had been a steady decline in the supply of hospital beds, from 874,000 in 1995, to 805,000 in 2006.13 These factors have exacerbated the problem of ED overcrowding and boarding.

Not only does boarding entail additional consumption of space, resources, equipment, and manpower, it also potentially compromises patient safety. Typically, hospitalists and inpatient medical teams are engaged in providing care to patients in the wards, while ED physicians and nurses are busy taking care of newly‐arrived ED patients. Non‐ED physicians may have the false impression that their boarded patients, while in the ED, are receiving continuous care and so may decide to delay seeing these patients, which can jeopardize the quality and timeliness of care. Studies have shown that ED overcrowding may potentially lead to poor patient care and outcomes and increased risk for medical errors.1416 ED overcrowding potentially causes multiple effects, including prolonging patient pain and suffering, long patient waiting time, patient dissatisfaction, ambulance diversions, decreased physician productivity, and increased frustration among medical staff.15 In a report by the Joint Commission Accreditation of Healthcare Organizations,17 ED overcrowding was cited as a significant contributing factor in sentinel event cases of patient death or permanent injury due to delays in treatment. Boarding critically ill patients who are physiologically vulnerable and unstable can allow them to be subjected to treatment delays at a pivotal point when time‐sensitive interventions are necessary, ie, sepsis or cardiogenic shockthe golden hour in trauma.16 Medical errors are usually not caused by individual errors but by complex hospital systems; and ED overcrowding is a prime example of a system problem that creates a high‐risk environment for medical errors and threatens patient safety.18

Our hospital commonly has 5 to 15 boarders and often has 20 to 30 boarders at any time. Approximately 90% of these patients are admitted to the Medical Service. In response to this challenge, our institution has designated a full‐time hospitalist to manage boarded patients. The primary goal of this new role is to ensure patient safety and the delivery of high‐quality care while admitted patients are in the ED (Table 1).

Responsibilities of the ED Hospitalist
  • Abbreviation: ED, emergency department.

1Round on all patients admitted to the Department of Medicine located in the ED, including those on the Teaching and Nonteaching Services. Rounds focus on patient safety, such as ensuring vital home and hospital medications are administered and changes in stability are noted. All patient updates are documented in the ED electronic medical records (IBEX).
2Identify admitted patients who may be downgraded from telemetry to nontelemetry status. Telemetry and cardiac beds are in high demand, and decreasing utilization facilitates obtaining the appropriate ward bed for ED patients.
3Assess admitted patients for possible discharge. The patient's condition may have improved or results may indicate that admission is no longer required. The ED hospitalist communicates with the ED physician and wards teams, facilitates management, implements the discharge, and ensures adequate follow‐up.
4Refer patients to an ED social worker as needed.
5Facilitate referrals to other medical or surgical specialties if indicated.
6Clarify the plan of care with the ED staff and facilitates ED communication with the ward team. Acts as a liaison and a resource for the ED physicians and nursing staff.
7Supervise the triage duties of the medical admitting resident.
8Provide medical consultation to ED physicians for patients not being admitted to the hospital or who are being admitted to other services (eg, surgery).

The objectives of the study were to determine: (1) the impact on quality of care by assessing laboratory results acted upon and medication follow‐up by the ED hospitalist, and (2) the impact on throughput by assessing the number of ED discharges and telemetry downgrades.

Methods

Setting

The Mount Sinai Medical Center is a tertiary‐care 1121‐bed acute care teaching hospital located in New York City. The hospital borders East Harlem and the Upper East Side of Manhattan. The Medical Service is composed of a Teaching Service, composed of house staff and attendings, and a non‐Teaching Service, composed of nurse practitioners, physician assistants, and attendings. Hospitalists and private attendings may have patients on either the Teaching or the non‐Teaching Service. In 2007, there were 56,541 patients admitted for a total of 332,368 days. The mean LOS for medical inpatients was 5.89 days. The total ED visit was 79,500 with a total inpatient and critical care admissions of 24,522. The mean and median LOS for all ED patients were 623 minutes and 493 minutes, respectively. There were 11,488 patients who qualified as boarders, averaging 31.5 boarders per 24 hours; with a mean and median LOS per boarder of 288 minutes and 198 minutes, respectively. The ED LOS for admitted patients ranged from 2 minutes to 4074 minutes (2.83 days).

Admission Process

Once an ED attending physician decides that a patient is to be admitted, the patient is placed on a computerized list in the ED's electronic medical record (IBEX software). The Medical Admitting Resident (MAR) evaluates and triages admitted patients, and assigns and gives a verbal report to the appropriate Medicine Service (ie, Teaching, non‐Teaching, cardiac telemetry unit, intensive care, etc.). The Admitting Office searches for and assigns the appropriate unit and bed for the patient. A hospitalist or resident physician performs the patient's initial assessment and evaluation in the ED, and admission orders are placed in the inpatient computerized order entry system (TDS). When the bed is ready, the ED nurse gives a verbal report to the floor nurse, and the patient is transported to the ward.

Responsibilities

The specific responsibilities of the ED hospitalist are listed in Table 1. The primary role is to round on patients admitted to the Medicine Service who are located in the ED. This encompasses a wide array of patients and services, including patients assigned to a hospitalist service attending or who have a private attending, patients admitted to the Teaching or non‐Teaching Service, patients admitted to the intensive care unit, and patients admitted to a general medicine or specialty service (eg, telemetry, oncology, human immunodeficiency virus [HIV]). Rounding includes review of the ED's electronic medical record as well as direct examination of patients. The hospitalist focuses on patients with longer ED LOS and on aspects of care that may lapse while patients remain in the ED for prolonged periods. At our institution, the follow‐up of subsequent tests, laboratory values, and medications for ED boarders is the responsibility of the primary inpatient team, though the ED physicians act on urgent and critical results and continue to deliver all emergency care. Through rounding, the ED hospitalist is able to identify abnormal results in a timely manner, alert the ED physician and primary inpatient team, and address abnormalities. Specific examples of laboratory results acted upon include hypokalemia, hyperglycemia, and elevated cardiac enzymes. The ED hospitalist is also able to determine whether any outpatient medications have not yet been administered (eg, antihypertensives, immune suppressants) and ensure that subsequent doses of medications initiated in the ED (eg, antibiotics) are administered during the appropriate timeframe.

Communication is emphasized, as contact with ED physicians, ward physicians, and often the outpatient primary care physician is required when any change in management is considered. The ED hospitalist also provides the capability of rapid response to changes in patient status (eg, a new complaint or fever). In addition, the hospitalist is available to consult on medical patients who may not require admission and on nonmedical patients for whom an internal medicine consult may be beneficial (eg, preoperative optimization of a surgical patient). The ED hospitalist documents the evaluation in the IBEX system. Bills were submitted for visits in which patients were discharged as these encounters are comprehensive, but not for other encounters.

Data Collection

The ED hospitalist role began March 10, 2008 and is a 10‐hour shift (8 AM to 6 PM) on weekdays. The study period was from March 10, 2008 through June 30, 2008. The study was approved by the hospital's institutional review board.

Data were collected on aspects of care that could have been impacted by the ED hospitalist, including medication and laboratory orders, ED discharges, ED admissions avoided, and telemetry downgrades. Discharges from ED refers to boarded admitted patients in the ED, who by the judgment of the ED hospitalist were ready for discharge. Admissions avoided refers to patients who the ED physician planned to admit but had not yet been admitted, and whose admission was avoided through the recommendations made by the ED hospitalist. The ED LOS was defined as the duration of time from when the patient was admitted to the Medicine Service to the time the patient was transferred to a medical ward. Telemetry downgrades were defined as patients assigned to the cardiac telemetry unit who the hospitalist determined required only telemetry on a general medical unit or did not require telemetry, or patients assigned to telemetry on a general medicine unit who the hospitalist determined no longer required telemetry.

Results were expressed as percentages of patients admitted to a Medicine Service and percentage of patients evaluated by the ED hospitalist, as indicated. 95% confidence intervals (CI) were calculated.

Results

During the study period, there were 4363 patients admitted to the Medicine Service and 3555 patients who qualified as boarders (mean of 29 boarders per 24 hours). The mean boarding time of admitted patients was 440 minutes. A total of 634 patients (17.8% of all boarded patients) were evaluated by the ED hospitalist. The mean daily number of patients seen by the ED hospitalist was 8.0.

The key elements of the delivery of care by the ED hospitalist are summarized in Table 2.

Elements of Care Delivered by the ED Hospitalist to ED Boarders
ElementsBoarders (n = 3555) [n (%)]Patients Intervened on (n = 634) [n (%)]
  • Abbreviation: ED, emergency department.

  • Forty‐four patients improved and 2 left against medical advice.

Laboratory results acted upon472 (13.2)472 (74.5)
Medication follow‐up506 (14.2)506 (79.8)
Discharges from the ED*46 (1.3)46 (7.3)
Admissions avoided6 (0.2)6 (0.95)
Telemetry downgrades61 (1.8)61 (9.6)

The care of boarded patients included follow‐up of laboratory tests for 74.5% (95% CI, 71‐78%) and medication orders for 79.8% (95% CI, 77‐83%) of patients. A total of 46 patients were discharged by the ED hospitalist (0.6 discharges/day) and telemetry was discontinued for 61 patients (0.8 downgrades/day). The discharge rate was 7.3% (95% CI, 5‐10%) and telemetry downgrade rate was 9.6% (95% CI, 8‐12%) of those patients assessed by the ED hospitalist. Expressed as a percentage of the total ED boarders (n = 3555), the combined discharge rate and the admissions avoided rate was 1.5%.

Table 3 shows the discharge diagnoses made from the ED. Chest pain was the most common diagnosis, followed by syncope, pneumonia, and chronic obstructive pulmonary disease (COPD).

Diagnoses of Patients Discharged from the ED by the ED Hospitalist
DiagnosesPatients (n = 46) [n (%)]
  • Abbreviations: COPD, chronic obstructive pulmonary disease; ED, emergency department.

Chest pain12 (26)
Syncope/dizziness7 (15)
Pneumonia4 (9)
COPD4 (9)
Congestive heart failure3 (7)
Gastroenteritis3 (7)
Dermatitis/rash3 (7)
Alcohol abuse3 (7)
Abdominal pain3 (7)
End stage renal disease2 (4)
Vaginal bleeding1 (2)
Fall1 (2)
Asthma1 (2)

Discussion

Our hospital has successfully implemented an innovative strategy utilizing a hospitalist to help provide seamless care to medical patients located in the ED. Other solutions at our hospital had previously been implemented, but had not adequately addressed the problem, including: (1) protocols to monitor length of stay patterns and deviations, (2) discharge planning activities, (3) organized computerized bed tracking, (4) improvement in the timeliness of ancillary services, (5) daily bed briefing among nurse managers, and (6) 24‐hour presence of a MAR to facilitate triage in the ED.

The current study demonstrates the potential for substantial impact on patient care. The substantial number of the assessed boarder patients for whom laboratory tests (74.5%) and medications (79.8%) were ordered by the ED hospitalists suggests that the quality and timeliness of care was enhanced by this initiative. In addition, the considerable number of patients discharged from the ED and downgraded from telemetry (1.5% and 1.8% of all boarder patients, respectively) suggests that an ED hospitalist may have a meaningful impact on bed utilization and thus decrease ED overcrowding. In 2007, there were 11,488 who qualified as boarders; our data suggest that an ED hospitalist would result in approximately 172 boarders not being admitted annually.

Though the ED LOS was higher during the study period compared to 2007, it was lower than the 2 months immediately preceding implementation of the ED hospitalist role. The ED LOS was 732 and 658 minutes for January and February 2008, respectively, which was markedly increased from 2007 (288 minutes), and prompted development of the ED hospitalist role. The ED LOS during the study period subsequently decreased to 440 minutes. Though the wide fluctuations in ED LOS and the short time period with high ED LOS prior to implementation preclude concluding that the ED hospitalist role decreased ED LOS, the data suggest that an ED hospitalist may be able to improve ED throughput.

The majority of the discharges made by the ED hospitalist are patients who had been admitted for chest pain, had improved, and had negative cardiac enzymes and stress tests. Patients with syncope who were discharged were likely patients without any comorbidities. The COPD and pneumonia admissions were likely patients who improved after aggressive treatment in the ED.

The impact of ED overcrowding on the quality of patient care and outcomes may be substantial. Hwang et al.19 found a direct correlation between ED census and time to pain assessment and administration of analgesic medication. A study at an academic medical center found that higher ED volume was associated with less likelihood of antibiotics being administered within 4 hours for patients with community‐acquired pneumonia.20 A comprehensive review of the literature identified 41 studies examining the effects of ED overcrowding on clinical outcomes and the investigators noted that ED overcrowding was associated with increased in‐hospital mortality.8

Causes of poor outcomes during periods of overcrowding may be the high volume of acute patients preventing adequate time and attention for each ED patient, as well as confusion during the transition from ED to ward physicians. For example, a patient may receive their initial dose of antibiotics from the ED physician, but subsequent doses may be overlooked in the transition of care from the ED physician to the inpatient team. In addition, having admitted patients located in the ED for extended periods of time may lead to these patients not being seen as frequently as patients admitted to the inpatient wards. Another potential consequence of prolonged ED stay for admitted patients is delay in inpatient management. Tests done in the ED may prompt further studies that may not be ordered promptly while patients remain in the ED, which subsequently increases LOS. Other potential issues may be an increase in confusion among geriatric patients in a noisy and crowded ED; decreased access to specialized nursing care that may be available on a hospital ward; decreased access to physical therapy and occupational therapy services; and decreased comfort and satisfaction as patients wait in overcrowded EDs for prolonged periods.

Several other potential innovative solutions to ED overcrowding have been proposed, studied, and tested. These measures generally are focused on improving the three interdependent components of ED workflow: INPUT THROUGHPUT OUTPUT.21, 22 However, process redesign and intervention on these 3 interdependent ED workflow components may be difficult to achieve, especially when hospital resources are limited and when inpatient hospital capacity is already maximized. In some institutions, efforts have been reported to successfully streamline the transfer of admitted ED patients to inpatient beds, through transfer‐to‐ward policy interventions (eg, physician coordinators for patient flow and bed management or transfers made within a defined period of time).2326 However, in a study by Quinn et al.,27 implementation of a rapid admission policy resulted in a decrease of only 10.1 minutes in the ED LOS. Several studies have demonstrated the benefits of an acute medical admissions unit in alleviating ED overcrowding.28, 29 Other unconventional solutions by some hospitals include sending admitted patients to the unit's hallways or placing discharged patients in the hallway while waiting for transportation so that the ED bed will be readily available.30

The ED hospitalist is well‐situated to have an impact on several key hospital outcomes. As the ED hospitalist role was shown to affect processes that relate to ED throughput, it is possible that the role will improve ED overcrowding and decrease ED LOS. Specifically, identifying patients who can be discharged and for whom telemetry is no longer indicated decreases unnecessary bed utilization and allows these beds to be available for other ED patients. This initiative also may promote patient satisfaction by assuring patients that their medical and concerns are being fully addressed while they are in the ED. Increased emphasis on hospital reporting will make patient satisfaction a priority for many hospitals, and the ED hospitalist will be in a unique position to meet and greet patients admitted to the Medicine Service and to reassure them that the medical team is present and addressing their concerns. The hospitalist's ability to facilitate diagnostic testing and treatment while patients remain in the ED may also help decrease the total LOS in the hospital. In addition, the ED hospitalist is also in position to recognize social factors at the earliest stage of admission so that they can be immediately addressed. Future studies will need to be done to determine if this model of transitional care impacts these important factors.

Our study has several important limitations. Most notably, the lack of a comparison interval for which a hospitalist was not assigned to this role prevents us from drawing any definitive conclusions on the benefits of the ED hospitalist model. Also, we collected only summary data and do not have demographic data on the patients managed by the ED hospitalist or information on the ED course of patients who were discharged or had telemetry downgraded. This prevents determination of whether discharged patients did not require admission initially or whose condition evolved over a prolonged ED stay. In addition, other key outcomes, such as patient satisfaction and satisfaction of the ED physicians and nursing staff have not yet been formally measured. Future studies will be needed to determine if an ED hospital model can improve important process and clinical outcomes.

The greatest challenge of this initiative was introducing and familiarizing this role to the key stakeholders, including the ED physicians and nursing staff, house staff, and private practice physicians. Though we did not perform structured surveys on satisfaction, through informal discussions we noted that the role was welcomed with enthusiasm by the ED physicians. Notably, several ED physicians expressed appreciation that they were able to focus their care on new ED patients rather than on the boarded ED patients. Through feedback, we noted soon after implementation that ED faculty and nurses needed further clarification about the potential overlapping roles of the ED hospitalist and ED physicians and ward physicians. These concerns were addressed by educational sessions and announcements, including presentations at ED faculty and staff meetings. The hospitalist assigned to the role each month received individualized orientation prior to assuming the role, and an ED Hospitalist Manual was distributed. Possibly due to these focused sessions, the hospitalists assigned to the role became quickly acclimated.

Conclusions

We have found that designating a hospitalist to directly address the care of ED boarders can enhance the quality and timeliness of care and decrease bed and telemetry utilization with the potential to impact ED and hospital LOS. Given the success of the pilot model, the role was expanded at our institution to 10 hours per day, 7 days per week. Hospitals struggling to address the needs of their admitted patients in the ED should consider incorporating an ED hospitalist to enhance clinical care and address issues relating to throughput. A follow‐up study is needed to more precisely describe the impact of the ED hospitalist model.

References
  1. Weiss SJ, Derlet R, Arnhdal J, et al.Estimating the degree of emergency department overcrowding in academic medical centers: results of the National ED Overcrowding Study (NEDOCS).Acad Emerg Med.2004;11:3850.
  2. Bond K, Ospina MB, Blitz S, et al.Frequency, determinants, and impact of overcrowding in emergency departments in Canada: a national survey.Healthc Q.2007;10:3240.
  3. Steele R, Kiss A.EMDOC (emergency department overcrowding) internet‐based safety net research.Admin Emerg Med.2008;35:101107.
  4. United States General Accounting Office.Hospital Emergency Departments: Crowded Conditions Vary Among Hospitals and Communities. March 2003.Washington, DC:General Accounting Office;2003.
  5. Derlet RW.Overcrowding in emergency department: increased demand and decreased capacity.Ann Emerg Med.2002;39:430432.
  6. Rathlev NK, Chessare J, Olshaker J, et al.Time series analysis of variables associated with daily mean emergency department length of stay.Ann Emerg Med.2007;49:265271.
  7. Forster A, Stiell I, Wells G, et al.Effect of hospital occupancy on emergency department length of stay and patient disposition.Ann Emerg Med.2003;10:127133.
  8. Bersnstein SL, Aronsky D, Duseja R, et al.The effect of emergency department crowding on clinically oriented outcomes.Acad Emerg Med.2009;16:110.
  9. Rondeau KV, Francescutti LH.Emergency department overcrowding: the impact of resource scarcity on physician job satisfaction.J Health Manag.2005;50:327340.
  10. Pines JM, Iyer S, Disbot M, Hollander JE, Shofer FS, Datner EM.The effect of emergency department crowding on patient satisfaction for admitted patients.Acad Emerg Med.2008;15:825831.
  11. Vieth TL, Rhodes KV.The effect of crowding on access and quality in an academic ED.Am J Emerg Med.2006;24:787794.
  12. Nawar EW, Niska RW, Xu J.National Hospital Ambulatory Medical Care Survey: 2005 Emergency Department Summary. Advance Data from Vital and Health Statistics. No. 386.Hyattsville, MD:National Center for Health Statistics;2007.
  13. American Hospital Association (AHA).Table 1: Historical trends in utilization, personnel, and finances: year 1946–2006.AHA Hospital Statistics.2008 ed.Chicago:Health Forum LLC;2008:3.
  14. Trzeciak S, Rivers EP.Emergency department overcrowding in the US: an emerging threat to patient safety and public health.Emerg Med J.2003;20:402405.
  15. Derlet RW, Richards JR.Overcrowding in the nation's emergency departments: complex causes and disturbing effects.Ann Emerg Med.2000;35:6368.
  16. Cowan RM, Trzeciak S.Clinical review: emergency department overcrowding and the potential impact on the critically ill.Crit Care.2005;9:291295.
  17. Joint Commission on Accreditation of Healthcare Organizations (JCAHO): Sentinel event alert 2002, Issue 26. Available at: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_26.htm. Accessed October2009.
  18. Gordon JA, Billings J, Asplin BR, et al.Safety net research in emergency medicine: proceedings of the Academic Emergency Consensus Conference on “The Unraveling Safety Net.”Acad Emerg Med.2001;8:10241029.
  19. Hwang U, Richardson L, Livote E, Harris B, Spencer N, Morrison SR.Emergency department crowding and decreased quality of pain care.Acad Emerg Med.2008;15:12481256.
  20. Fee C, Weber EJ, Maak CA, Bacchetti P.Effect of emergency department crowding on time to antibiotics in patients admitted with community‐acquired pneumonia.Ann Emerg Med.2007;50:501509.
  21. Asplin BR, Magid DJ, Rhodes KV, et al.A conceptual model of emergency department crowding.Ann Emerg Med.2003;42:173180.
  22. Solberg LI, Asplin BR, Weinick RM, et al.Emergency department crowding: consensus development of potential measures.Ann Emerg Med.2003;42:824834.
  23. Cardin S, Afilalo M, Lang E, et al.Intervention to decrease emergency department crowding: does it have an effect on return visits and hospital readmission?Ann Emerg Med.2003;41:173–185.
  24. Spaite DW, Bartholomeaux F, Guisto JM, et al.Rapid process design in a university‐based emergency department: decreasing waiting time intervals and improving patient satisfaction.Ann Emerg Med.2002;39:168177.
  25. Viccellio P.Emergency department crowding: an action plan.Acad Emerg Med.2001;18:185187.
  26. Howell EE, Bessman ES, Rubin HR.Hospitalists and an innovative emergency department admission process.J Gen Intern Med.2004;19:266268.
  27. Quinn JV, Mahadevan SV, Eggers G et al.Effects of implementing a rapid admission policy in the ED.Am J Emerg Med.2007;25:559563.
  28. Kelen GD, Scheulen PA, Hill PM.Effect of an emergency department managed acute care unit on ED overcrowding and emergency medical services diversion.Acad Emerg Med.2001;8:10851100.
  29. Maloney ED, Bennett K, O'Riordan D, Silke B.Emergency department census of patients awaiting admission following reorganization of an admissions process.Emerg Med J.2006;23:363367.
  30. Greene J.Emergency department flow and the boarded patient: how to get admitted patients upstairs.Ann Emerg Med.2007;49:6870.
Article PDF
Issue
Journal of Hospital Medicine - 5(6)
Publications
Page Number
360-364
Sections
Article PDF
Article PDF

Emergency Department (ED) overcrowding has become an important problem in North American hospitals.13 A national survey identified the prolonged length of stay of admitted patients in the ED as the most frequent reason for overcrowding.4 This complex problem occurs when hospital inpatient census increases and prevents admitted patients from being assigned and transported to hospital beds in a timely manner.5 The practice of holding admitted patients in the ED, known as boarding, is typically defined as the length of stay (LOS) in ED beginning 2 hours after the time of admission to the time of transfer to the wards.

In a study of daily mean ED LOS, Rathlev et al.6 concluded that a 5% increase in hospital occupancy resulted in 14 hours of holding time for all patients in the ED, and an observational study found that when hospital occupancy exceeds a threshold of 90%, the ED LOS for admitted patients correspondingly increased.7 Thus, efforts to decrease overcrowding will need to address both ED and hospital throughput and LOS. Most importantly, overcrowding has important consequences on physician and patient satisfaction and the quality of patient care.811

Between 1995 and 2005, ED visits rose 20% from 96.5 million to 115.3 million visits annually, while the number of hospital EDs decreased from 4176 to 3795, making an overall 7% increase in ED utilization rate.12 Similarly, there was a 12% increase in the total inpatient admissions for all registered hospitals in the United States from 31 million in 1995 to 35.3 million in 2005.13 However, despite this increase in demand of ED utilization and inpatient admissions, there had been a steady decline in the supply of hospital beds, from 874,000 in 1995, to 805,000 in 2006.13 These factors have exacerbated the problem of ED overcrowding and boarding.

Not only does boarding entail additional consumption of space, resources, equipment, and manpower, it also potentially compromises patient safety. Typically, hospitalists and inpatient medical teams are engaged in providing care to patients in the wards, while ED physicians and nurses are busy taking care of newly‐arrived ED patients. Non‐ED physicians may have the false impression that their boarded patients, while in the ED, are receiving continuous care and so may decide to delay seeing these patients, which can jeopardize the quality and timeliness of care. Studies have shown that ED overcrowding may potentially lead to poor patient care and outcomes and increased risk for medical errors.1416 ED overcrowding potentially causes multiple effects, including prolonging patient pain and suffering, long patient waiting time, patient dissatisfaction, ambulance diversions, decreased physician productivity, and increased frustration among medical staff.15 In a report by the Joint Commission Accreditation of Healthcare Organizations,17 ED overcrowding was cited as a significant contributing factor in sentinel event cases of patient death or permanent injury due to delays in treatment. Boarding critically ill patients who are physiologically vulnerable and unstable can allow them to be subjected to treatment delays at a pivotal point when time‐sensitive interventions are necessary, ie, sepsis or cardiogenic shockthe golden hour in trauma.16 Medical errors are usually not caused by individual errors but by complex hospital systems; and ED overcrowding is a prime example of a system problem that creates a high‐risk environment for medical errors and threatens patient safety.18

Our hospital commonly has 5 to 15 boarders and often has 20 to 30 boarders at any time. Approximately 90% of these patients are admitted to the Medical Service. In response to this challenge, our institution has designated a full‐time hospitalist to manage boarded patients. The primary goal of this new role is to ensure patient safety and the delivery of high‐quality care while admitted patients are in the ED (Table 1).

Responsibilities of the ED Hospitalist
  • Abbreviation: ED, emergency department.

1Round on all patients admitted to the Department of Medicine located in the ED, including those on the Teaching and Nonteaching Services. Rounds focus on patient safety, such as ensuring vital home and hospital medications are administered and changes in stability are noted. All patient updates are documented in the ED electronic medical records (IBEX).
2Identify admitted patients who may be downgraded from telemetry to nontelemetry status. Telemetry and cardiac beds are in high demand, and decreasing utilization facilitates obtaining the appropriate ward bed for ED patients.
3Assess admitted patients for possible discharge. The patient's condition may have improved or results may indicate that admission is no longer required. The ED hospitalist communicates with the ED physician and wards teams, facilitates management, implements the discharge, and ensures adequate follow‐up.
4Refer patients to an ED social worker as needed.
5Facilitate referrals to other medical or surgical specialties if indicated.
6Clarify the plan of care with the ED staff and facilitates ED communication with the ward team. Acts as a liaison and a resource for the ED physicians and nursing staff.
7Supervise the triage duties of the medical admitting resident.
8Provide medical consultation to ED physicians for patients not being admitted to the hospital or who are being admitted to other services (eg, surgery).

The objectives of the study were to determine: (1) the impact on quality of care by assessing laboratory results acted upon and medication follow‐up by the ED hospitalist, and (2) the impact on throughput by assessing the number of ED discharges and telemetry downgrades.

Methods

Setting

The Mount Sinai Medical Center is a tertiary‐care 1121‐bed acute care teaching hospital located in New York City. The hospital borders East Harlem and the Upper East Side of Manhattan. The Medical Service is composed of a Teaching Service, composed of house staff and attendings, and a non‐Teaching Service, composed of nurse practitioners, physician assistants, and attendings. Hospitalists and private attendings may have patients on either the Teaching or the non‐Teaching Service. In 2007, there were 56,541 patients admitted for a total of 332,368 days. The mean LOS for medical inpatients was 5.89 days. The total ED visit was 79,500 with a total inpatient and critical care admissions of 24,522. The mean and median LOS for all ED patients were 623 minutes and 493 minutes, respectively. There were 11,488 patients who qualified as boarders, averaging 31.5 boarders per 24 hours; with a mean and median LOS per boarder of 288 minutes and 198 minutes, respectively. The ED LOS for admitted patients ranged from 2 minutes to 4074 minutes (2.83 days).

Admission Process

Once an ED attending physician decides that a patient is to be admitted, the patient is placed on a computerized list in the ED's electronic medical record (IBEX software). The Medical Admitting Resident (MAR) evaluates and triages admitted patients, and assigns and gives a verbal report to the appropriate Medicine Service (ie, Teaching, non‐Teaching, cardiac telemetry unit, intensive care, etc.). The Admitting Office searches for and assigns the appropriate unit and bed for the patient. A hospitalist or resident physician performs the patient's initial assessment and evaluation in the ED, and admission orders are placed in the inpatient computerized order entry system (TDS). When the bed is ready, the ED nurse gives a verbal report to the floor nurse, and the patient is transported to the ward.

Responsibilities

The specific responsibilities of the ED hospitalist are listed in Table 1. The primary role is to round on patients admitted to the Medicine Service who are located in the ED. This encompasses a wide array of patients and services, including patients assigned to a hospitalist service attending or who have a private attending, patients admitted to the Teaching or non‐Teaching Service, patients admitted to the intensive care unit, and patients admitted to a general medicine or specialty service (eg, telemetry, oncology, human immunodeficiency virus [HIV]). Rounding includes review of the ED's electronic medical record as well as direct examination of patients. The hospitalist focuses on patients with longer ED LOS and on aspects of care that may lapse while patients remain in the ED for prolonged periods. At our institution, the follow‐up of subsequent tests, laboratory values, and medications for ED boarders is the responsibility of the primary inpatient team, though the ED physicians act on urgent and critical results and continue to deliver all emergency care. Through rounding, the ED hospitalist is able to identify abnormal results in a timely manner, alert the ED physician and primary inpatient team, and address abnormalities. Specific examples of laboratory results acted upon include hypokalemia, hyperglycemia, and elevated cardiac enzymes. The ED hospitalist is also able to determine whether any outpatient medications have not yet been administered (eg, antihypertensives, immune suppressants) and ensure that subsequent doses of medications initiated in the ED (eg, antibiotics) are administered during the appropriate timeframe.

Communication is emphasized, as contact with ED physicians, ward physicians, and often the outpatient primary care physician is required when any change in management is considered. The ED hospitalist also provides the capability of rapid response to changes in patient status (eg, a new complaint or fever). In addition, the hospitalist is available to consult on medical patients who may not require admission and on nonmedical patients for whom an internal medicine consult may be beneficial (eg, preoperative optimization of a surgical patient). The ED hospitalist documents the evaluation in the IBEX system. Bills were submitted for visits in which patients were discharged as these encounters are comprehensive, but not for other encounters.

Data Collection

The ED hospitalist role began March 10, 2008 and is a 10‐hour shift (8 AM to 6 PM) on weekdays. The study period was from March 10, 2008 through June 30, 2008. The study was approved by the hospital's institutional review board.

Data were collected on aspects of care that could have been impacted by the ED hospitalist, including medication and laboratory orders, ED discharges, ED admissions avoided, and telemetry downgrades. Discharges from ED refers to boarded admitted patients in the ED, who by the judgment of the ED hospitalist were ready for discharge. Admissions avoided refers to patients who the ED physician planned to admit but had not yet been admitted, and whose admission was avoided through the recommendations made by the ED hospitalist. The ED LOS was defined as the duration of time from when the patient was admitted to the Medicine Service to the time the patient was transferred to a medical ward. Telemetry downgrades were defined as patients assigned to the cardiac telemetry unit who the hospitalist determined required only telemetry on a general medical unit or did not require telemetry, or patients assigned to telemetry on a general medicine unit who the hospitalist determined no longer required telemetry.

Results were expressed as percentages of patients admitted to a Medicine Service and percentage of patients evaluated by the ED hospitalist, as indicated. 95% confidence intervals (CI) were calculated.

Results

During the study period, there were 4363 patients admitted to the Medicine Service and 3555 patients who qualified as boarders (mean of 29 boarders per 24 hours). The mean boarding time of admitted patients was 440 minutes. A total of 634 patients (17.8% of all boarded patients) were evaluated by the ED hospitalist. The mean daily number of patients seen by the ED hospitalist was 8.0.

The key elements of the delivery of care by the ED hospitalist are summarized in Table 2.

Elements of Care Delivered by the ED Hospitalist to ED Boarders
ElementsBoarders (n = 3555) [n (%)]Patients Intervened on (n = 634) [n (%)]
  • Abbreviation: ED, emergency department.

  • Forty‐four patients improved and 2 left against medical advice.

Laboratory results acted upon472 (13.2)472 (74.5)
Medication follow‐up506 (14.2)506 (79.8)
Discharges from the ED*46 (1.3)46 (7.3)
Admissions avoided6 (0.2)6 (0.95)
Telemetry downgrades61 (1.8)61 (9.6)

The care of boarded patients included follow‐up of laboratory tests for 74.5% (95% CI, 71‐78%) and medication orders for 79.8% (95% CI, 77‐83%) of patients. A total of 46 patients were discharged by the ED hospitalist (0.6 discharges/day) and telemetry was discontinued for 61 patients (0.8 downgrades/day). The discharge rate was 7.3% (95% CI, 5‐10%) and telemetry downgrade rate was 9.6% (95% CI, 8‐12%) of those patients assessed by the ED hospitalist. Expressed as a percentage of the total ED boarders (n = 3555), the combined discharge rate and the admissions avoided rate was 1.5%.

Table 3 shows the discharge diagnoses made from the ED. Chest pain was the most common diagnosis, followed by syncope, pneumonia, and chronic obstructive pulmonary disease (COPD).

Diagnoses of Patients Discharged from the ED by the ED Hospitalist
DiagnosesPatients (n = 46) [n (%)]
  • Abbreviations: COPD, chronic obstructive pulmonary disease; ED, emergency department.

Chest pain12 (26)
Syncope/dizziness7 (15)
Pneumonia4 (9)
COPD4 (9)
Congestive heart failure3 (7)
Gastroenteritis3 (7)
Dermatitis/rash3 (7)
Alcohol abuse3 (7)
Abdominal pain3 (7)
End stage renal disease2 (4)
Vaginal bleeding1 (2)
Fall1 (2)
Asthma1 (2)

Discussion

Our hospital has successfully implemented an innovative strategy utilizing a hospitalist to help provide seamless care to medical patients located in the ED. Other solutions at our hospital had previously been implemented, but had not adequately addressed the problem, including: (1) protocols to monitor length of stay patterns and deviations, (2) discharge planning activities, (3) organized computerized bed tracking, (4) improvement in the timeliness of ancillary services, (5) daily bed briefing among nurse managers, and (6) 24‐hour presence of a MAR to facilitate triage in the ED.

The current study demonstrates the potential for substantial impact on patient care. The substantial number of the assessed boarder patients for whom laboratory tests (74.5%) and medications (79.8%) were ordered by the ED hospitalists suggests that the quality and timeliness of care was enhanced by this initiative. In addition, the considerable number of patients discharged from the ED and downgraded from telemetry (1.5% and 1.8% of all boarder patients, respectively) suggests that an ED hospitalist may have a meaningful impact on bed utilization and thus decrease ED overcrowding. In 2007, there were 11,488 who qualified as boarders; our data suggest that an ED hospitalist would result in approximately 172 boarders not being admitted annually.

Though the ED LOS was higher during the study period compared to 2007, it was lower than the 2 months immediately preceding implementation of the ED hospitalist role. The ED LOS was 732 and 658 minutes for January and February 2008, respectively, which was markedly increased from 2007 (288 minutes), and prompted development of the ED hospitalist role. The ED LOS during the study period subsequently decreased to 440 minutes. Though the wide fluctuations in ED LOS and the short time period with high ED LOS prior to implementation preclude concluding that the ED hospitalist role decreased ED LOS, the data suggest that an ED hospitalist may be able to improve ED throughput.

The majority of the discharges made by the ED hospitalist are patients who had been admitted for chest pain, had improved, and had negative cardiac enzymes and stress tests. Patients with syncope who were discharged were likely patients without any comorbidities. The COPD and pneumonia admissions were likely patients who improved after aggressive treatment in the ED.

The impact of ED overcrowding on the quality of patient care and outcomes may be substantial. Hwang et al.19 found a direct correlation between ED census and time to pain assessment and administration of analgesic medication. A study at an academic medical center found that higher ED volume was associated with less likelihood of antibiotics being administered within 4 hours for patients with community‐acquired pneumonia.20 A comprehensive review of the literature identified 41 studies examining the effects of ED overcrowding on clinical outcomes and the investigators noted that ED overcrowding was associated with increased in‐hospital mortality.8

Causes of poor outcomes during periods of overcrowding may be the high volume of acute patients preventing adequate time and attention for each ED patient, as well as confusion during the transition from ED to ward physicians. For example, a patient may receive their initial dose of antibiotics from the ED physician, but subsequent doses may be overlooked in the transition of care from the ED physician to the inpatient team. In addition, having admitted patients located in the ED for extended periods of time may lead to these patients not being seen as frequently as patients admitted to the inpatient wards. Another potential consequence of prolonged ED stay for admitted patients is delay in inpatient management. Tests done in the ED may prompt further studies that may not be ordered promptly while patients remain in the ED, which subsequently increases LOS. Other potential issues may be an increase in confusion among geriatric patients in a noisy and crowded ED; decreased access to specialized nursing care that may be available on a hospital ward; decreased access to physical therapy and occupational therapy services; and decreased comfort and satisfaction as patients wait in overcrowded EDs for prolonged periods.

Several other potential innovative solutions to ED overcrowding have been proposed, studied, and tested. These measures generally are focused on improving the three interdependent components of ED workflow: INPUT THROUGHPUT OUTPUT.21, 22 However, process redesign and intervention on these 3 interdependent ED workflow components may be difficult to achieve, especially when hospital resources are limited and when inpatient hospital capacity is already maximized. In some institutions, efforts have been reported to successfully streamline the transfer of admitted ED patients to inpatient beds, through transfer‐to‐ward policy interventions (eg, physician coordinators for patient flow and bed management or transfers made within a defined period of time).2326 However, in a study by Quinn et al.,27 implementation of a rapid admission policy resulted in a decrease of only 10.1 minutes in the ED LOS. Several studies have demonstrated the benefits of an acute medical admissions unit in alleviating ED overcrowding.28, 29 Other unconventional solutions by some hospitals include sending admitted patients to the unit's hallways or placing discharged patients in the hallway while waiting for transportation so that the ED bed will be readily available.30

The ED hospitalist is well‐situated to have an impact on several key hospital outcomes. As the ED hospitalist role was shown to affect processes that relate to ED throughput, it is possible that the role will improve ED overcrowding and decrease ED LOS. Specifically, identifying patients who can be discharged and for whom telemetry is no longer indicated decreases unnecessary bed utilization and allows these beds to be available for other ED patients. This initiative also may promote patient satisfaction by assuring patients that their medical and concerns are being fully addressed while they are in the ED. Increased emphasis on hospital reporting will make patient satisfaction a priority for many hospitals, and the ED hospitalist will be in a unique position to meet and greet patients admitted to the Medicine Service and to reassure them that the medical team is present and addressing their concerns. The hospitalist's ability to facilitate diagnostic testing and treatment while patients remain in the ED may also help decrease the total LOS in the hospital. In addition, the ED hospitalist is also in position to recognize social factors at the earliest stage of admission so that they can be immediately addressed. Future studies will need to be done to determine if this model of transitional care impacts these important factors.

Our study has several important limitations. Most notably, the lack of a comparison interval for which a hospitalist was not assigned to this role prevents us from drawing any definitive conclusions on the benefits of the ED hospitalist model. Also, we collected only summary data and do not have demographic data on the patients managed by the ED hospitalist or information on the ED course of patients who were discharged or had telemetry downgraded. This prevents determination of whether discharged patients did not require admission initially or whose condition evolved over a prolonged ED stay. In addition, other key outcomes, such as patient satisfaction and satisfaction of the ED physicians and nursing staff have not yet been formally measured. Future studies will be needed to determine if an ED hospital model can improve important process and clinical outcomes.

The greatest challenge of this initiative was introducing and familiarizing this role to the key stakeholders, including the ED physicians and nursing staff, house staff, and private practice physicians. Though we did not perform structured surveys on satisfaction, through informal discussions we noted that the role was welcomed with enthusiasm by the ED physicians. Notably, several ED physicians expressed appreciation that they were able to focus their care on new ED patients rather than on the boarded ED patients. Through feedback, we noted soon after implementation that ED faculty and nurses needed further clarification about the potential overlapping roles of the ED hospitalist and ED physicians and ward physicians. These concerns were addressed by educational sessions and announcements, including presentations at ED faculty and staff meetings. The hospitalist assigned to the role each month received individualized orientation prior to assuming the role, and an ED Hospitalist Manual was distributed. Possibly due to these focused sessions, the hospitalists assigned to the role became quickly acclimated.

Conclusions

We have found that designating a hospitalist to directly address the care of ED boarders can enhance the quality and timeliness of care and decrease bed and telemetry utilization with the potential to impact ED and hospital LOS. Given the success of the pilot model, the role was expanded at our institution to 10 hours per day, 7 days per week. Hospitals struggling to address the needs of their admitted patients in the ED should consider incorporating an ED hospitalist to enhance clinical care and address issues relating to throughput. A follow‐up study is needed to more precisely describe the impact of the ED hospitalist model.

Emergency Department (ED) overcrowding has become an important problem in North American hospitals.13 A national survey identified the prolonged length of stay of admitted patients in the ED as the most frequent reason for overcrowding.4 This complex problem occurs when hospital inpatient census increases and prevents admitted patients from being assigned and transported to hospital beds in a timely manner.5 The practice of holding admitted patients in the ED, known as boarding, is typically defined as the length of stay (LOS) in ED beginning 2 hours after the time of admission to the time of transfer to the wards.

In a study of daily mean ED LOS, Rathlev et al.6 concluded that a 5% increase in hospital occupancy resulted in 14 hours of holding time for all patients in the ED, and an observational study found that when hospital occupancy exceeds a threshold of 90%, the ED LOS for admitted patients correspondingly increased.7 Thus, efforts to decrease overcrowding will need to address both ED and hospital throughput and LOS. Most importantly, overcrowding has important consequences on physician and patient satisfaction and the quality of patient care.811

Between 1995 and 2005, ED visits rose 20% from 96.5 million to 115.3 million visits annually, while the number of hospital EDs decreased from 4176 to 3795, making an overall 7% increase in ED utilization rate.12 Similarly, there was a 12% increase in the total inpatient admissions for all registered hospitals in the United States from 31 million in 1995 to 35.3 million in 2005.13 However, despite this increase in demand of ED utilization and inpatient admissions, there had been a steady decline in the supply of hospital beds, from 874,000 in 1995, to 805,000 in 2006.13 These factors have exacerbated the problem of ED overcrowding and boarding.

Not only does boarding entail additional consumption of space, resources, equipment, and manpower, it also potentially compromises patient safety. Typically, hospitalists and inpatient medical teams are engaged in providing care to patients in the wards, while ED physicians and nurses are busy taking care of newly‐arrived ED patients. Non‐ED physicians may have the false impression that their boarded patients, while in the ED, are receiving continuous care and so may decide to delay seeing these patients, which can jeopardize the quality and timeliness of care. Studies have shown that ED overcrowding may potentially lead to poor patient care and outcomes and increased risk for medical errors.1416 ED overcrowding potentially causes multiple effects, including prolonging patient pain and suffering, long patient waiting time, patient dissatisfaction, ambulance diversions, decreased physician productivity, and increased frustration among medical staff.15 In a report by the Joint Commission Accreditation of Healthcare Organizations,17 ED overcrowding was cited as a significant contributing factor in sentinel event cases of patient death or permanent injury due to delays in treatment. Boarding critically ill patients who are physiologically vulnerable and unstable can allow them to be subjected to treatment delays at a pivotal point when time‐sensitive interventions are necessary, ie, sepsis or cardiogenic shockthe golden hour in trauma.16 Medical errors are usually not caused by individual errors but by complex hospital systems; and ED overcrowding is a prime example of a system problem that creates a high‐risk environment for medical errors and threatens patient safety.18

Our hospital commonly has 5 to 15 boarders and often has 20 to 30 boarders at any time. Approximately 90% of these patients are admitted to the Medical Service. In response to this challenge, our institution has designated a full‐time hospitalist to manage boarded patients. The primary goal of this new role is to ensure patient safety and the delivery of high‐quality care while admitted patients are in the ED (Table 1).

Responsibilities of the ED Hospitalist
  • Abbreviation: ED, emergency department.

1Round on all patients admitted to the Department of Medicine located in the ED, including those on the Teaching and Nonteaching Services. Rounds focus on patient safety, such as ensuring vital home and hospital medications are administered and changes in stability are noted. All patient updates are documented in the ED electronic medical records (IBEX).
2Identify admitted patients who may be downgraded from telemetry to nontelemetry status. Telemetry and cardiac beds are in high demand, and decreasing utilization facilitates obtaining the appropriate ward bed for ED patients.
3Assess admitted patients for possible discharge. The patient's condition may have improved or results may indicate that admission is no longer required. The ED hospitalist communicates with the ED physician and wards teams, facilitates management, implements the discharge, and ensures adequate follow‐up.
4Refer patients to an ED social worker as needed.
5Facilitate referrals to other medical or surgical specialties if indicated.
6Clarify the plan of care with the ED staff and facilitates ED communication with the ward team. Acts as a liaison and a resource for the ED physicians and nursing staff.
7Supervise the triage duties of the medical admitting resident.
8Provide medical consultation to ED physicians for patients not being admitted to the hospital or who are being admitted to other services (eg, surgery).

The objectives of the study were to determine: (1) the impact on quality of care by assessing laboratory results acted upon and medication follow‐up by the ED hospitalist, and (2) the impact on throughput by assessing the number of ED discharges and telemetry downgrades.

Methods

Setting

The Mount Sinai Medical Center is a tertiary‐care 1121‐bed acute care teaching hospital located in New York City. The hospital borders East Harlem and the Upper East Side of Manhattan. The Medical Service is composed of a Teaching Service, composed of house staff and attendings, and a non‐Teaching Service, composed of nurse practitioners, physician assistants, and attendings. Hospitalists and private attendings may have patients on either the Teaching or the non‐Teaching Service. In 2007, there were 56,541 patients admitted for a total of 332,368 days. The mean LOS for medical inpatients was 5.89 days. The total ED visit was 79,500 with a total inpatient and critical care admissions of 24,522. The mean and median LOS for all ED patients were 623 minutes and 493 minutes, respectively. There were 11,488 patients who qualified as boarders, averaging 31.5 boarders per 24 hours; with a mean and median LOS per boarder of 288 minutes and 198 minutes, respectively. The ED LOS for admitted patients ranged from 2 minutes to 4074 minutes (2.83 days).

Admission Process

Once an ED attending physician decides that a patient is to be admitted, the patient is placed on a computerized list in the ED's electronic medical record (IBEX software). The Medical Admitting Resident (MAR) evaluates and triages admitted patients, and assigns and gives a verbal report to the appropriate Medicine Service (ie, Teaching, non‐Teaching, cardiac telemetry unit, intensive care, etc.). The Admitting Office searches for and assigns the appropriate unit and bed for the patient. A hospitalist or resident physician performs the patient's initial assessment and evaluation in the ED, and admission orders are placed in the inpatient computerized order entry system (TDS). When the bed is ready, the ED nurse gives a verbal report to the floor nurse, and the patient is transported to the ward.

Responsibilities

The specific responsibilities of the ED hospitalist are listed in Table 1. The primary role is to round on patients admitted to the Medicine Service who are located in the ED. This encompasses a wide array of patients and services, including patients assigned to a hospitalist service attending or who have a private attending, patients admitted to the Teaching or non‐Teaching Service, patients admitted to the intensive care unit, and patients admitted to a general medicine or specialty service (eg, telemetry, oncology, human immunodeficiency virus [HIV]). Rounding includes review of the ED's electronic medical record as well as direct examination of patients. The hospitalist focuses on patients with longer ED LOS and on aspects of care that may lapse while patients remain in the ED for prolonged periods. At our institution, the follow‐up of subsequent tests, laboratory values, and medications for ED boarders is the responsibility of the primary inpatient team, though the ED physicians act on urgent and critical results and continue to deliver all emergency care. Through rounding, the ED hospitalist is able to identify abnormal results in a timely manner, alert the ED physician and primary inpatient team, and address abnormalities. Specific examples of laboratory results acted upon include hypokalemia, hyperglycemia, and elevated cardiac enzymes. The ED hospitalist is also able to determine whether any outpatient medications have not yet been administered (eg, antihypertensives, immune suppressants) and ensure that subsequent doses of medications initiated in the ED (eg, antibiotics) are administered during the appropriate timeframe.

Communication is emphasized, as contact with ED physicians, ward physicians, and often the outpatient primary care physician is required when any change in management is considered. The ED hospitalist also provides the capability of rapid response to changes in patient status (eg, a new complaint or fever). In addition, the hospitalist is available to consult on medical patients who may not require admission and on nonmedical patients for whom an internal medicine consult may be beneficial (eg, preoperative optimization of a surgical patient). The ED hospitalist documents the evaluation in the IBEX system. Bills were submitted for visits in which patients were discharged as these encounters are comprehensive, but not for other encounters.

Data Collection

The ED hospitalist role began March 10, 2008 and is a 10‐hour shift (8 AM to 6 PM) on weekdays. The study period was from March 10, 2008 through June 30, 2008. The study was approved by the hospital's institutional review board.

Data were collected on aspects of care that could have been impacted by the ED hospitalist, including medication and laboratory orders, ED discharges, ED admissions avoided, and telemetry downgrades. Discharges from ED refers to boarded admitted patients in the ED, who by the judgment of the ED hospitalist were ready for discharge. Admissions avoided refers to patients who the ED physician planned to admit but had not yet been admitted, and whose admission was avoided through the recommendations made by the ED hospitalist. The ED LOS was defined as the duration of time from when the patient was admitted to the Medicine Service to the time the patient was transferred to a medical ward. Telemetry downgrades were defined as patients assigned to the cardiac telemetry unit who the hospitalist determined required only telemetry on a general medical unit or did not require telemetry, or patients assigned to telemetry on a general medicine unit who the hospitalist determined no longer required telemetry.

Results were expressed as percentages of patients admitted to a Medicine Service and percentage of patients evaluated by the ED hospitalist, as indicated. 95% confidence intervals (CI) were calculated.

Results

During the study period, there were 4363 patients admitted to the Medicine Service and 3555 patients who qualified as boarders (mean of 29 boarders per 24 hours). The mean boarding time of admitted patients was 440 minutes. A total of 634 patients (17.8% of all boarded patients) were evaluated by the ED hospitalist. The mean daily number of patients seen by the ED hospitalist was 8.0.

The key elements of the delivery of care by the ED hospitalist are summarized in Table 2.

Elements of Care Delivered by the ED Hospitalist to ED Boarders
ElementsBoarders (n = 3555) [n (%)]Patients Intervened on (n = 634) [n (%)]
  • Abbreviation: ED, emergency department.

  • Forty‐four patients improved and 2 left against medical advice.

Laboratory results acted upon472 (13.2)472 (74.5)
Medication follow‐up506 (14.2)506 (79.8)
Discharges from the ED*46 (1.3)46 (7.3)
Admissions avoided6 (0.2)6 (0.95)
Telemetry downgrades61 (1.8)61 (9.6)

The care of boarded patients included follow‐up of laboratory tests for 74.5% (95% CI, 71‐78%) and medication orders for 79.8% (95% CI, 77‐83%) of patients. A total of 46 patients were discharged by the ED hospitalist (0.6 discharges/day) and telemetry was discontinued for 61 patients (0.8 downgrades/day). The discharge rate was 7.3% (95% CI, 5‐10%) and telemetry downgrade rate was 9.6% (95% CI, 8‐12%) of those patients assessed by the ED hospitalist. Expressed as a percentage of the total ED boarders (n = 3555), the combined discharge rate and the admissions avoided rate was 1.5%.

Table 3 shows the discharge diagnoses made from the ED. Chest pain was the most common diagnosis, followed by syncope, pneumonia, and chronic obstructive pulmonary disease (COPD).

Diagnoses of Patients Discharged from the ED by the ED Hospitalist
DiagnosesPatients (n = 46) [n (%)]
  • Abbreviations: COPD, chronic obstructive pulmonary disease; ED, emergency department.

Chest pain12 (26)
Syncope/dizziness7 (15)
Pneumonia4 (9)
COPD4 (9)
Congestive heart failure3 (7)
Gastroenteritis3 (7)
Dermatitis/rash3 (7)
Alcohol abuse3 (7)
Abdominal pain3 (7)
End stage renal disease2 (4)
Vaginal bleeding1 (2)
Fall1 (2)
Asthma1 (2)

Discussion

Our hospital has successfully implemented an innovative strategy utilizing a hospitalist to help provide seamless care to medical patients located in the ED. Other solutions at our hospital had previously been implemented, but had not adequately addressed the problem, including: (1) protocols to monitor length of stay patterns and deviations, (2) discharge planning activities, (3) organized computerized bed tracking, (4) improvement in the timeliness of ancillary services, (5) daily bed briefing among nurse managers, and (6) 24‐hour presence of a MAR to facilitate triage in the ED.

The current study demonstrates the potential for substantial impact on patient care. The substantial number of the assessed boarder patients for whom laboratory tests (74.5%) and medications (79.8%) were ordered by the ED hospitalists suggests that the quality and timeliness of care was enhanced by this initiative. In addition, the considerable number of patients discharged from the ED and downgraded from telemetry (1.5% and 1.8% of all boarder patients, respectively) suggests that an ED hospitalist may have a meaningful impact on bed utilization and thus decrease ED overcrowding. In 2007, there were 11,488 who qualified as boarders; our data suggest that an ED hospitalist would result in approximately 172 boarders not being admitted annually.

Though the ED LOS was higher during the study period compared to 2007, it was lower than the 2 months immediately preceding implementation of the ED hospitalist role. The ED LOS was 732 and 658 minutes for January and February 2008, respectively, which was markedly increased from 2007 (288 minutes), and prompted development of the ED hospitalist role. The ED LOS during the study period subsequently decreased to 440 minutes. Though the wide fluctuations in ED LOS and the short time period with high ED LOS prior to implementation preclude concluding that the ED hospitalist role decreased ED LOS, the data suggest that an ED hospitalist may be able to improve ED throughput.

The majority of the discharges made by the ED hospitalist are patients who had been admitted for chest pain, had improved, and had negative cardiac enzymes and stress tests. Patients with syncope who were discharged were likely patients without any comorbidities. The COPD and pneumonia admissions were likely patients who improved after aggressive treatment in the ED.

The impact of ED overcrowding on the quality of patient care and outcomes may be substantial. Hwang et al.19 found a direct correlation between ED census and time to pain assessment and administration of analgesic medication. A study at an academic medical center found that higher ED volume was associated with less likelihood of antibiotics being administered within 4 hours for patients with community‐acquired pneumonia.20 A comprehensive review of the literature identified 41 studies examining the effects of ED overcrowding on clinical outcomes and the investigators noted that ED overcrowding was associated with increased in‐hospital mortality.8

Causes of poor outcomes during periods of overcrowding may be the high volume of acute patients preventing adequate time and attention for each ED patient, as well as confusion during the transition from ED to ward physicians. For example, a patient may receive their initial dose of antibiotics from the ED physician, but subsequent doses may be overlooked in the transition of care from the ED physician to the inpatient team. In addition, having admitted patients located in the ED for extended periods of time may lead to these patients not being seen as frequently as patients admitted to the inpatient wards. Another potential consequence of prolonged ED stay for admitted patients is delay in inpatient management. Tests done in the ED may prompt further studies that may not be ordered promptly while patients remain in the ED, which subsequently increases LOS. Other potential issues may be an increase in confusion among geriatric patients in a noisy and crowded ED; decreased access to specialized nursing care that may be available on a hospital ward; decreased access to physical therapy and occupational therapy services; and decreased comfort and satisfaction as patients wait in overcrowded EDs for prolonged periods.

Several other potential innovative solutions to ED overcrowding have been proposed, studied, and tested. These measures generally are focused on improving the three interdependent components of ED workflow: INPUT THROUGHPUT OUTPUT.21, 22 However, process redesign and intervention on these 3 interdependent ED workflow components may be difficult to achieve, especially when hospital resources are limited and when inpatient hospital capacity is already maximized. In some institutions, efforts have been reported to successfully streamline the transfer of admitted ED patients to inpatient beds, through transfer‐to‐ward policy interventions (eg, physician coordinators for patient flow and bed management or transfers made within a defined period of time).2326 However, in a study by Quinn et al.,27 implementation of a rapid admission policy resulted in a decrease of only 10.1 minutes in the ED LOS. Several studies have demonstrated the benefits of an acute medical admissions unit in alleviating ED overcrowding.28, 29 Other unconventional solutions by some hospitals include sending admitted patients to the unit's hallways or placing discharged patients in the hallway while waiting for transportation so that the ED bed will be readily available.30

The ED hospitalist is well‐situated to have an impact on several key hospital outcomes. As the ED hospitalist role was shown to affect processes that relate to ED throughput, it is possible that the role will improve ED overcrowding and decrease ED LOS. Specifically, identifying patients who can be discharged and for whom telemetry is no longer indicated decreases unnecessary bed utilization and allows these beds to be available for other ED patients. This initiative also may promote patient satisfaction by assuring patients that their medical and concerns are being fully addressed while they are in the ED. Increased emphasis on hospital reporting will make patient satisfaction a priority for many hospitals, and the ED hospitalist will be in a unique position to meet and greet patients admitted to the Medicine Service and to reassure them that the medical team is present and addressing their concerns. The hospitalist's ability to facilitate diagnostic testing and treatment while patients remain in the ED may also help decrease the total LOS in the hospital. In addition, the ED hospitalist is also in position to recognize social factors at the earliest stage of admission so that they can be immediately addressed. Future studies will need to be done to determine if this model of transitional care impacts these important factors.

Our study has several important limitations. Most notably, the lack of a comparison interval for which a hospitalist was not assigned to this role prevents us from drawing any definitive conclusions on the benefits of the ED hospitalist model. Also, we collected only summary data and do not have demographic data on the patients managed by the ED hospitalist or information on the ED course of patients who were discharged or had telemetry downgraded. This prevents determination of whether discharged patients did not require admission initially or whose condition evolved over a prolonged ED stay. In addition, other key outcomes, such as patient satisfaction and satisfaction of the ED physicians and nursing staff have not yet been formally measured. Future studies will be needed to determine if an ED hospital model can improve important process and clinical outcomes.

The greatest challenge of this initiative was introducing and familiarizing this role to the key stakeholders, including the ED physicians and nursing staff, house staff, and private practice physicians. Though we did not perform structured surveys on satisfaction, through informal discussions we noted that the role was welcomed with enthusiasm by the ED physicians. Notably, several ED physicians expressed appreciation that they were able to focus their care on new ED patients rather than on the boarded ED patients. Through feedback, we noted soon after implementation that ED faculty and nurses needed further clarification about the potential overlapping roles of the ED hospitalist and ED physicians and ward physicians. These concerns were addressed by educational sessions and announcements, including presentations at ED faculty and staff meetings. The hospitalist assigned to the role each month received individualized orientation prior to assuming the role, and an ED Hospitalist Manual was distributed. Possibly due to these focused sessions, the hospitalists assigned to the role became quickly acclimated.

Conclusions

We have found that designating a hospitalist to directly address the care of ED boarders can enhance the quality and timeliness of care and decrease bed and telemetry utilization with the potential to impact ED and hospital LOS. Given the success of the pilot model, the role was expanded at our institution to 10 hours per day, 7 days per week. Hospitals struggling to address the needs of their admitted patients in the ED should consider incorporating an ED hospitalist to enhance clinical care and address issues relating to throughput. A follow‐up study is needed to more precisely describe the impact of the ED hospitalist model.

References
  1. Weiss SJ, Derlet R, Arnhdal J, et al.Estimating the degree of emergency department overcrowding in academic medical centers: results of the National ED Overcrowding Study (NEDOCS).Acad Emerg Med.2004;11:3850.
  2. Bond K, Ospina MB, Blitz S, et al.Frequency, determinants, and impact of overcrowding in emergency departments in Canada: a national survey.Healthc Q.2007;10:3240.
  3. Steele R, Kiss A.EMDOC (emergency department overcrowding) internet‐based safety net research.Admin Emerg Med.2008;35:101107.
  4. United States General Accounting Office.Hospital Emergency Departments: Crowded Conditions Vary Among Hospitals and Communities. March 2003.Washington, DC:General Accounting Office;2003.
  5. Derlet RW.Overcrowding in emergency department: increased demand and decreased capacity.Ann Emerg Med.2002;39:430432.
  6. Rathlev NK, Chessare J, Olshaker J, et al.Time series analysis of variables associated with daily mean emergency department length of stay.Ann Emerg Med.2007;49:265271.
  7. Forster A, Stiell I, Wells G, et al.Effect of hospital occupancy on emergency department length of stay and patient disposition.Ann Emerg Med.2003;10:127133.
  8. Bersnstein SL, Aronsky D, Duseja R, et al.The effect of emergency department crowding on clinically oriented outcomes.Acad Emerg Med.2009;16:110.
  9. Rondeau KV, Francescutti LH.Emergency department overcrowding: the impact of resource scarcity on physician job satisfaction.J Health Manag.2005;50:327340.
  10. Pines JM, Iyer S, Disbot M, Hollander JE, Shofer FS, Datner EM.The effect of emergency department crowding on patient satisfaction for admitted patients.Acad Emerg Med.2008;15:825831.
  11. Vieth TL, Rhodes KV.The effect of crowding on access and quality in an academic ED.Am J Emerg Med.2006;24:787794.
  12. Nawar EW, Niska RW, Xu J.National Hospital Ambulatory Medical Care Survey: 2005 Emergency Department Summary. Advance Data from Vital and Health Statistics. No. 386.Hyattsville, MD:National Center for Health Statistics;2007.
  13. American Hospital Association (AHA).Table 1: Historical trends in utilization, personnel, and finances: year 1946–2006.AHA Hospital Statistics.2008 ed.Chicago:Health Forum LLC;2008:3.
  14. Trzeciak S, Rivers EP.Emergency department overcrowding in the US: an emerging threat to patient safety and public health.Emerg Med J.2003;20:402405.
  15. Derlet RW, Richards JR.Overcrowding in the nation's emergency departments: complex causes and disturbing effects.Ann Emerg Med.2000;35:6368.
  16. Cowan RM, Trzeciak S.Clinical review: emergency department overcrowding and the potential impact on the critically ill.Crit Care.2005;9:291295.
  17. Joint Commission on Accreditation of Healthcare Organizations (JCAHO): Sentinel event alert 2002, Issue 26. Available at: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_26.htm. Accessed October2009.
  18. Gordon JA, Billings J, Asplin BR, et al.Safety net research in emergency medicine: proceedings of the Academic Emergency Consensus Conference on “The Unraveling Safety Net.”Acad Emerg Med.2001;8:10241029.
  19. Hwang U, Richardson L, Livote E, Harris B, Spencer N, Morrison SR.Emergency department crowding and decreased quality of pain care.Acad Emerg Med.2008;15:12481256.
  20. Fee C, Weber EJ, Maak CA, Bacchetti P.Effect of emergency department crowding on time to antibiotics in patients admitted with community‐acquired pneumonia.Ann Emerg Med.2007;50:501509.
  21. Asplin BR, Magid DJ, Rhodes KV, et al.A conceptual model of emergency department crowding.Ann Emerg Med.2003;42:173180.
  22. Solberg LI, Asplin BR, Weinick RM, et al.Emergency department crowding: consensus development of potential measures.Ann Emerg Med.2003;42:824834.
  23. Cardin S, Afilalo M, Lang E, et al.Intervention to decrease emergency department crowding: does it have an effect on return visits and hospital readmission?Ann Emerg Med.2003;41:173–185.
  24. Spaite DW, Bartholomeaux F, Guisto JM, et al.Rapid process design in a university‐based emergency department: decreasing waiting time intervals and improving patient satisfaction.Ann Emerg Med.2002;39:168177.
  25. Viccellio P.Emergency department crowding: an action plan.Acad Emerg Med.2001;18:185187.
  26. Howell EE, Bessman ES, Rubin HR.Hospitalists and an innovative emergency department admission process.J Gen Intern Med.2004;19:266268.
  27. Quinn JV, Mahadevan SV, Eggers G et al.Effects of implementing a rapid admission policy in the ED.Am J Emerg Med.2007;25:559563.
  28. Kelen GD, Scheulen PA, Hill PM.Effect of an emergency department managed acute care unit on ED overcrowding and emergency medical services diversion.Acad Emerg Med.2001;8:10851100.
  29. Maloney ED, Bennett K, O'Riordan D, Silke B.Emergency department census of patients awaiting admission following reorganization of an admissions process.Emerg Med J.2006;23:363367.
  30. Greene J.Emergency department flow and the boarded patient: how to get admitted patients upstairs.Ann Emerg Med.2007;49:6870.
References
  1. Weiss SJ, Derlet R, Arnhdal J, et al.Estimating the degree of emergency department overcrowding in academic medical centers: results of the National ED Overcrowding Study (NEDOCS).Acad Emerg Med.2004;11:3850.
  2. Bond K, Ospina MB, Blitz S, et al.Frequency, determinants, and impact of overcrowding in emergency departments in Canada: a national survey.Healthc Q.2007;10:3240.
  3. Steele R, Kiss A.EMDOC (emergency department overcrowding) internet‐based safety net research.Admin Emerg Med.2008;35:101107.
  4. United States General Accounting Office.Hospital Emergency Departments: Crowded Conditions Vary Among Hospitals and Communities. March 2003.Washington, DC:General Accounting Office;2003.
  5. Derlet RW.Overcrowding in emergency department: increased demand and decreased capacity.Ann Emerg Med.2002;39:430432.
  6. Rathlev NK, Chessare J, Olshaker J, et al.Time series analysis of variables associated with daily mean emergency department length of stay.Ann Emerg Med.2007;49:265271.
  7. Forster A, Stiell I, Wells G, et al.Effect of hospital occupancy on emergency department length of stay and patient disposition.Ann Emerg Med.2003;10:127133.
  8. Bersnstein SL, Aronsky D, Duseja R, et al.The effect of emergency department crowding on clinically oriented outcomes.Acad Emerg Med.2009;16:110.
  9. Rondeau KV, Francescutti LH.Emergency department overcrowding: the impact of resource scarcity on physician job satisfaction.J Health Manag.2005;50:327340.
  10. Pines JM, Iyer S, Disbot M, Hollander JE, Shofer FS, Datner EM.The effect of emergency department crowding on patient satisfaction for admitted patients.Acad Emerg Med.2008;15:825831.
  11. Vieth TL, Rhodes KV.The effect of crowding on access and quality in an academic ED.Am J Emerg Med.2006;24:787794.
  12. Nawar EW, Niska RW, Xu J.National Hospital Ambulatory Medical Care Survey: 2005 Emergency Department Summary. Advance Data from Vital and Health Statistics. No. 386.Hyattsville, MD:National Center for Health Statistics;2007.
  13. American Hospital Association (AHA).Table 1: Historical trends in utilization, personnel, and finances: year 1946–2006.AHA Hospital Statistics.2008 ed.Chicago:Health Forum LLC;2008:3.
  14. Trzeciak S, Rivers EP.Emergency department overcrowding in the US: an emerging threat to patient safety and public health.Emerg Med J.2003;20:402405.
  15. Derlet RW, Richards JR.Overcrowding in the nation's emergency departments: complex causes and disturbing effects.Ann Emerg Med.2000;35:6368.
  16. Cowan RM, Trzeciak S.Clinical review: emergency department overcrowding and the potential impact on the critically ill.Crit Care.2005;9:291295.
  17. Joint Commission on Accreditation of Healthcare Organizations (JCAHO): Sentinel event alert 2002, Issue 26. Available at: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_26.htm. Accessed October2009.
  18. Gordon JA, Billings J, Asplin BR, et al.Safety net research in emergency medicine: proceedings of the Academic Emergency Consensus Conference on “The Unraveling Safety Net.”Acad Emerg Med.2001;8:10241029.
  19. Hwang U, Richardson L, Livote E, Harris B, Spencer N, Morrison SR.Emergency department crowding and decreased quality of pain care.Acad Emerg Med.2008;15:12481256.
  20. Fee C, Weber EJ, Maak CA, Bacchetti P.Effect of emergency department crowding on time to antibiotics in patients admitted with community‐acquired pneumonia.Ann Emerg Med.2007;50:501509.
  21. Asplin BR, Magid DJ, Rhodes KV, et al.A conceptual model of emergency department crowding.Ann Emerg Med.2003;42:173180.
  22. Solberg LI, Asplin BR, Weinick RM, et al.Emergency department crowding: consensus development of potential measures.Ann Emerg Med.2003;42:824834.
  23. Cardin S, Afilalo M, Lang E, et al.Intervention to decrease emergency department crowding: does it have an effect on return visits and hospital readmission?Ann Emerg Med.2003;41:173–185.
  24. Spaite DW, Bartholomeaux F, Guisto JM, et al.Rapid process design in a university‐based emergency department: decreasing waiting time intervals and improving patient satisfaction.Ann Emerg Med.2002;39:168177.
  25. Viccellio P.Emergency department crowding: an action plan.Acad Emerg Med.2001;18:185187.
  26. Howell EE, Bessman ES, Rubin HR.Hospitalists and an innovative emergency department admission process.J Gen Intern Med.2004;19:266268.
  27. Quinn JV, Mahadevan SV, Eggers G et al.Effects of implementing a rapid admission policy in the ED.Am J Emerg Med.2007;25:559563.
  28. Kelen GD, Scheulen PA, Hill PM.Effect of an emergency department managed acute care unit on ED overcrowding and emergency medical services diversion.Acad Emerg Med.2001;8:10851100.
  29. Maloney ED, Bennett K, O'Riordan D, Silke B.Emergency department census of patients awaiting admission following reorganization of an admissions process.Emerg Med J.2006;23:363367.
  30. Greene J.Emergency department flow and the boarded patient: how to get admitted patients upstairs.Ann Emerg Med.2007;49:6870.
Issue
Journal of Hospital Medicine - 5(6)
Issue
Journal of Hospital Medicine - 5(6)
Page Number
360-364
Page Number
360-364
Publications
Publications
Article Type
Display Headline
A model of a hospitalist role in the care of admitted patients in the emergency department
Display Headline
A model of a hospitalist role in the care of admitted patients in the emergency department
Sections
Article Source

Copyright © 2009 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Division of General Internal Medicine, One Gustave L. Levy Place Box 1087, New York, NY 10029‐6574
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media